KLF的个人主页 - 老虎社区

KLF

KLF

暂无个人介绍

IP属地：未知

0关注

7粉丝

0主题

0勋章

2021-10-13

[流泪]

抱歉，原内容已删除

2021-12-27

Ok

抱歉，原内容已删除

2021-08-03

Sigh

抱歉，原内容已删除

2021-11-26

Good progress

Novavax: Some Burning Questions<blockquote>Novavax：一些紧迫的问题</blockquote>

2021-10-23

Oops

抱歉，原内容已删除

2021-12-01

Virus again....

抱歉，原内容已删除

2021-11-24

Sigh

抱歉，原内容已删除

2021-11-01

Hmm....

What's the best month for stocks? Hint: the next four weeks<blockquote>股票最好的月份是哪个月？提示：接下来的四周</blockquote>

2021-12-18

Sigh

Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>

2021-12-06

Hmm

Apple Stock: Slowing iPhone Demand Or Strong Quarter Ahead?<blockquote>苹果股票：iPhone需求放缓还是未来季度强劲？</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586729579943152","uuid":"3586729579943152","gmtCreate":1623635597723,"gmtModify":1624845917652,"name":"KLF","pinyin":"klf","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":0,"tweetSize":76,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":696402164,"gmtCreate":1640742933658,"gmtModify":1640742933814,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"hmm...//<a href=\"https://laohu8.com/U/3586729579943152\">@KLF</a>:Hmm","listText":"hmm...//<a href=\"https://laohu8.com/U/3586729579943152\">@KLF</a>:Hmm","text":"hmm...//@KLF:Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696402164","repostId":"1186633322","repostType":4,"isVote":1,"tweetType":1,"viewCount":2762,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696406343,"gmtCreate":1640742853997,"gmtModify":1640742854119,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696406343","repostId":"1186633322","repostType":4,"isVote":1,"tweetType":1,"viewCount":3035,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696825336,"gmtCreate":1640666883319,"gmtModify":1640668289900,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696825336","repostId":"1127544468","repostType":4,"isVote":1,"tweetType":1,"viewCount":3009,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069609,"gmtCreate":1640576292644,"gmtModify":1640576340157,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696069609","repostId":"2194380177","repostType":4,"isVote":1,"tweetType":1,"viewCount":2599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069101,"gmtCreate":1640576268799,"gmtModify":1640582033793,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069101","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","kind":"news","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=zh_CN&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-12-27 07:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY.AU":"SPDR® S&P 500® ETF Trust","BK4096":"电气部件与设备","FCEL":"燃料电池能源","BK4541":"氢能源"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1,"symbols_score_info":{"SPY.AU":0.9,"FCEL":0.9}},"isVote":1,"tweetType":1,"viewCount":2947,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698525922,"gmtCreate":1640474729455,"gmtModify":1640474729618,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698525922","repostId":"2193178191","repostType":4,"isVote":1,"tweetType":1,"viewCount":2833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698656208,"gmtCreate":1640391596614,"gmtModify":1640391596722,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Shocking","listText":"Shocking","text":"Shocking","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698656208","repostId":"1119237057","repostType":4,"repost":{"id":"1119237057","kind":"news","pubTimestamp":1640345779,"share":"https://www.laohu8.com/m/news/1119237057?lang=zh_CN&edition=full","pubTime":"2021-12-24 19:36","market":"us","language":"en","title":"Russian court fines Alphabet's Google $98 million<blockquote>俄罗斯法院对Alphabet旗下谷歌罚款9800万美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119237057","media":"RTE","summary":"A Moscow court has said it is fining Alphabet's Google 7.2 billion roubles ($98 million) for what it","content":"<p>A Moscow court has said it is fining Alphabet's Google 7.2 billion roubles ($98 million) for what it said was a repeated failure to delete content Russia deems illegal, the first revenue-based fine in this kind of case in Russia.</p><p><blockquote>莫斯科一家法院表示，将对Alphabet旗下的谷歌处以72亿卢布（9800万美元）的罚款，原因是谷歌多次未能删除俄罗斯认为非法的内容，这是俄罗斯此类案件中首次基于收入的罚款。</blockquote></p><p> Moscow has increased pressure on Big Tech this year in a campaign that critics characterise as an attempt by the Russian authorities to exert tighter control over the internet, something they say threatens to stifle individual and corporate freedom.</p><p><blockquote>莫斯科今年加大了对大型科技公司的压力，批评人士称这是俄罗斯当局试图对互联网施加更严格的控制，他们说这有可能扼杀个人和企业的自由。</blockquote></p><p></p>","source":"lsy1635981240902","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Russian court fines Alphabet's Google $98 million<blockquote>俄罗斯法院对Alphabet旗下谷歌罚款9800万美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRussian court fines Alphabet's Google $98 million<blockquote>俄罗斯法院对Alphabet旗下谷歌罚款9800万美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTE</strong><span class=\"h-time small\">2021-12-24 19:36</span>\n</p>\n</h4>\n</header>\n<article>\n<p>A Moscow court has said it is fining Alphabet's Google 7.2 billion roubles ($98 million) for what it said was a repeated failure to delete content Russia deems illegal, the first revenue-based fine in this kind of case in Russia.</p><p><blockquote>莫斯科一家法院表示，将对Alphabet旗下的谷歌处以72亿卢布（9800万美元）的罚款，原因是谷歌多次未能删除俄罗斯认为非法的内容，这是俄罗斯此类案件中首次基于收入的罚款。</blockquote></p><p> Moscow has increased pressure on Big Tech this year in a campaign that critics characterise as an attempt by the Russian authorities to exert tighter control over the internet, something they say threatens to stifle individual and corporate freedom.</p><p><blockquote>莫斯科今年加大了对大型科技公司的压力，批评人士称这是俄罗斯当局试图对互联网施加更严格的控制，他们说这有可能扼杀个人和企业的自由。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rte.ie/news/business/2021/1224/1268555-russian-court-fines-alphabets-google-98-million/\">RTE</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"source_url":"https://www.rte.ie/news/business/2021/1224/1268555-russian-court-fines-alphabets-google-98-million/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119237057","content_text":"A Moscow court has said it is fining Alphabet's Google 7.2 billion roubles ($98 million) for what it said was a repeated failure to delete content Russia deems illegal, the first revenue-based fine in this kind of case in Russia.\nMoscow has increased pressure on Big Tech this year in a campaign that critics characterise as an attempt by the Russian authorities to exert tighter control over the internet, something they say threatens to stifle individual and corporate freedom.","news_type":1,"symbols_score_info":{"GOOG":0.9,"GOOGL":0.9}},"isVote":1,"tweetType":1,"viewCount":2532,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698123305,"gmtCreate":1640322231219,"gmtModify":1640322231321,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698123305","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":2407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691421250,"gmtCreate":1640230052473,"gmtModify":1640230052618,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Oh...","listText":"Oh...","text":"Oh...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691421250","repostId":"1113992187","repostType":4,"isVote":1,"tweetType":1,"viewCount":2114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691675103,"gmtCreate":1640189267899,"gmtModify":1640189478039,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691675103","repostId":"2193920361","repostType":4,"isVote":1,"tweetType":1,"viewCount":2692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693527536,"gmtCreate":1640052016768,"gmtModify":1640054325577,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693527536","repostId":"1171374975","repostType":4,"isVote":1,"tweetType":1,"viewCount":1230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699457192,"gmtCreate":1639881744702,"gmtModify":1639881774903,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699457192","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":1208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699595170,"gmtCreate":1639833160564,"gmtModify":1639833202776,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699595170","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=zh_CN&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-18 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607843184,"gmtCreate":1639528102447,"gmtModify":1639528102581,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607843184","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":1355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607065523,"gmtCreate":1639460073952,"gmtModify":1639460084339,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607065523","repostId":"1199650124","repostType":4,"repost":{"id":"1199650124","kind":"news","pubTimestamp":1639458823,"share":"https://www.laohu8.com/m/news/1199650124?lang=zh_CN&edition=full","pubTime":"2021-12-14 13:13","market":"us","language":"en","title":"Apple Stock: It Could Make Sense To Trim The Position<blockquote>苹果股票：削减头寸可能是有意义的</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199650124","media":"TheStreet","summary":"Apple stock could be a compelling long-term “buy and hold” play. However, the vicious rally of the p","content":"<p>Apple stock could be a compelling long-term “buy and hold” play. However, the vicious rally of the past month may also mean that now is a good time to lock in some gains.</p><p><blockquote>苹果股票可能是一个引人注目的长期“买入并持有”股票。不过，过去一个月的恶性反弹也可能意味着，现在是锁定部分涨幅的好时机。</blockquote></p><p> Apple stock’s&nbsp;recent run has been impressive. Shares traded at nearly $180 in after-hours on Friday, December 10. If the stock price reaches $181.68 soon, per my estimates, Apple will have become the first company ever to be valued at $3 trillion.</p><p><blockquote>苹果股票最近的表现令人印象深刻。12月10日星期五，盘后股价接近180美元。根据我的估计，如果股价很快达到181.68美元，苹果将成为第一家估值达到3万亿美元的公司。</blockquote></p><p> Amid investor enthusiasm, however, I fear that AAPL may have moved too fast since mid-November. With the stock having outperformed the tech-rich Nasdaq index by a whopping 19.5 percentage points in the past month, could now be a good time to trim the position and lock in some gains?</p><p><blockquote>然而，在投资者的热情中，我担心苹果公司自11月中旬以来可能行动过快。由于该股过去一个月的表现优于科技股丰富的纳斯达克指数19.5个百分点，现在可能是削减头寸并锁定部分收益的好时机？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b8dea165a4c3f8375b37ab1560d20bec\" tg-width=\"1240\" tg-height=\"930\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple store in New York, NY.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：纽约州纽约市的苹果商店。</span></p></blockquote></p><p> <b>AAPL: impressive returns raise a flag</b></p><p><blockquote><b>苹果公司：令人印象深刻的回报树立了旗帜</b></blockquote></p><p> To start, I should make one thing very clear: in my opinion, Apple stock is&nbsp;a compelling long-term “buy and hold” play. In fact, I think that most growth-biased portfolios should be heavily exposed to shares of the Cupertino company, which I believe will outperform the rest of the market over the next, say, decade at least.</p><p><blockquote>首先，我应该非常明确地说明一件事：在我看来，苹果股票是一种引人注目的长期“买入并持有”股票。事实上，我认为大多数偏向增长的投资组合应该大量投资库比蒂诺公司的股票，我相信至少在未来十年内，该公司的表现将优于市场其他公司。</blockquote></p><p> That said, I like to keep tabs on short term price behavior as well. After plugging in the numbers, I was astonished to see that AAPL has topped the performance of the Nasdaq (QQQ) over a one-month period by the most since late August 2020: outperformance of +19.5%. For the past decade, AAPL’s December 2021 rally vs. the benchmark has been the second strongest.</p><p><blockquote>也就是说，我也喜欢密切关注短期价格行为。输入这些数字后，我惊讶地发现AAPL在一个月内的表现超过了纳斯达克(QQQ)，达到了自2020年8月下旬以来的最高水平：跑赢了+19.5%。在过去十年中，AAPL 2021年12月相对于基准的反弹一直是第二强劲的。</blockquote></p><p> Looking into the rearview mirror, this is great news for Apple shareholders. However, one should invest looking into the future. And that’s when the argument for buying Apple stock at $180 apiece today becomes a bit less compelling.</p><p><blockquote>看看后视镜，这对苹果股东来说是个好消息。然而，人们应该着眼于未来进行投资。这时，今天以每股180美元的价格购买苹果股票的论点就变得不那么令人信服了。</blockquote></p><p> The chart below shows the one-month performance of AAPL against QQQ over the past decade. Notice that the stock rarely beats the benchmark over such a short period of time by as much as it has in the past 4 to 5 weeks. The last time that it did, in August of last year, marked a peak in price of $134 that Apple stock still traded at until as recently as June 2021.</p><p><blockquote>下图显示了过去十年AAPL与QQQ的一个月表现。请注意，该股很少像过去4到5周那样在如此短的时间内跑赢基准。上一次这样做是在去年8月，当时苹果股票的交易价格达到了134美元的峰值，直到2021年6月。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fb283ad281bad9a0c0b1503520c823e3\" tg-width=\"787\" tg-height=\"468\" width=\"100%\" height=\"auto\"><span>Figure 2: 1-month performance: AAPL vs. QQQ.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：1个月表现：AAPL与QQQ。</span></p></blockquote></p><p> <b>So, will AAPL tank next?</b></p><p><blockquote><b>那么，苹果接下来会崩溃吗？</b></blockquote></p><p> To be crystal clear, none of the above means that Apple stock will likely nosedive in the foreseeable future. But think of investing like a game of blackjack. A player will certainly want to stand at 20 if the dealer’s up card is a 5, for example. Does it mean that, by doing so, the player is guaranteed to win that hand? No, it only means that the odds favor him or her.</p><p><blockquote>需要明确的是，上述情况并不意味着苹果股价在可预见的未来可能会暴跌。但是把投资想象成一场21点游戏。例如，如果庄家的向上牌是5，玩家肯定会想站在20。这是否意味着，通过这样做，玩家一定会赢得那手牌？不，这只意味着胜算对他或她有利。</blockquote></p><p> Likewise, buying Apple when the stock has handily outperformed the Nasdaq over the previous month has historically been disadvantageous. For example: over the past decade, AAPL has produced average one-year returns of +29%, assuming the stock is bought on any random day.</p><p><blockquote>同样，当苹果股票在过去一个月轻松跑赢纳斯达克时买入该股历来是不利的。例如：在过去十年中，假设在任意一天购买该股票，AAPL的平均一年回报率为+29%。</blockquote></p><p> However, this number would have been much lower if shares were bought on strength against the Nasdaq: only +8%, on average, following one-month outperformance of 10% or more against the benchmark. On the other end of the spectrum, average one-year return in AAPL would have been a much better +39% following one-month underperformance of -10% or worse against QQQ.</p><p><blockquote>然而，如果针对纳斯达克强势买入股票，这个数字会低得多：在一个月的表现优于基准10%或更多之后，平均仅+8%。另一方面，在QQQ一个月表现不佳-10%或更差之后，AAPL的平均一年回报率会好得多，为+39%。</blockquote></p><p> The observations above are consistent with&nbsp;the strategy of buying a stock on weakness&nbsp;to take advantage of an eventual rebound; and selling it on strength to lock in gains, some of which could have been produced by irrational bullishness.</p><p><blockquote>上述观察与逢低买入股票以利用最终反弹的策略是一致的；并强势抛售以锁定收益，其中一些收益可能是由非理性看涨产生的。</blockquote></p><p> <b>Panic and sell AAPL?</b></p><p><blockquote><b>恐慌并出售AAPL？</b></blockquote></p><p> At this point, I should reemphasize that I remain an Apple bull. I would not sell all my stake in the company only because the share price climbed from $150 to $180 as quickly as it has.</p><p><blockquote>在这一点上，我应该再次强调，我仍然是苹果多头。我不会仅仅因为股价从150美元迅速攀升至180美元就出售我在该公司的所有股份。</blockquote></p><p> However, I believe that now is a good time to think about rebalancing the portfolio. It seems prudent to me, following the recent rally, that some AAPL trimming and reallocation into other high-quality names would take place during this moment of strength in the stock.</p><p><blockquote>然而，我认为现在是考虑重新平衡投资组合的好时机。在我看来，在最近的反弹之后，在该股走强的时刻，苹果公司将进行一些削减并重新分配到其他高质量的股票中，这似乎是谨慎的。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: It Could Make Sense To Trim The Position<blockquote>苹果股票：削减头寸可能是有意义的</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: It Could Make Sense To Trim The Position<blockquote>苹果股票：削减头寸可能是有意义的</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-14 13:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple stock could be a compelling long-term “buy and hold” play. However, the vicious rally of the past month may also mean that now is a good time to lock in some gains.</p><p><blockquote>苹果股票可能是一个引人注目的长期“买入并持有”股票。不过，过去一个月的恶性反弹也可能意味着，现在是锁定部分涨幅的好时机。</blockquote></p><p> Apple stock’s&nbsp;recent run has been impressive. Shares traded at nearly $180 in after-hours on Friday, December 10. If the stock price reaches $181.68 soon, per my estimates, Apple will have become the first company ever to be valued at $3 trillion.</p><p><blockquote>苹果股票最近的表现令人印象深刻。12月10日星期五，盘后股价接近180美元。根据我的估计，如果股价很快达到181.68美元，苹果将成为第一家估值达到3万亿美元的公司。</blockquote></p><p> Amid investor enthusiasm, however, I fear that AAPL may have moved too fast since mid-November. With the stock having outperformed the tech-rich Nasdaq index by a whopping 19.5 percentage points in the past month, could now be a good time to trim the position and lock in some gains?</p><p><blockquote>然而，在投资者的热情中，我担心苹果公司自11月中旬以来可能行动过快。由于该股过去一个月的表现优于科技股丰富的纳斯达克指数19.5个百分点，现在可能是削减头寸并锁定部分收益的好时机？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b8dea165a4c3f8375b37ab1560d20bec\" tg-width=\"1240\" tg-height=\"930\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple store in New York, NY.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：纽约州纽约市的苹果商店。</span></p></blockquote></p><p> <b>AAPL: impressive returns raise a flag</b></p><p><blockquote><b>苹果公司：令人印象深刻的回报树立了旗帜</b></blockquote></p><p> To start, I should make one thing very clear: in my opinion, Apple stock is&nbsp;a compelling long-term “buy and hold” play. In fact, I think that most growth-biased portfolios should be heavily exposed to shares of the Cupertino company, which I believe will outperform the rest of the market over the next, say, decade at least.</p><p><blockquote>首先，我应该非常明确地说明一件事：在我看来，苹果股票是一种引人注目的长期“买入并持有”股票。事实上，我认为大多数偏向增长的投资组合应该大量投资库比蒂诺公司的股票，我相信至少在未来十年内，该公司的表现将优于市场其他公司。</blockquote></p><p> That said, I like to keep tabs on short term price behavior as well. After plugging in the numbers, I was astonished to see that AAPL has topped the performance of the Nasdaq (QQQ) over a one-month period by the most since late August 2020: outperformance of +19.5%. For the past decade, AAPL’s December 2021 rally vs. the benchmark has been the second strongest.</p><p><blockquote>也就是说，我也喜欢密切关注短期价格行为。输入这些数字后，我惊讶地发现AAPL在一个月内的表现超过了纳斯达克(QQQ)，达到了自2020年8月下旬以来的最高水平：跑赢了+19.5%。在过去十年中，AAPL 2021年12月相对于基准的反弹一直是第二强劲的。</blockquote></p><p> Looking into the rearview mirror, this is great news for Apple shareholders. However, one should invest looking into the future. And that’s when the argument for buying Apple stock at $180 apiece today becomes a bit less compelling.</p><p><blockquote>看看后视镜，这对苹果股东来说是个好消息。然而，人们应该着眼于未来进行投资。这时，今天以每股180美元的价格购买苹果股票的论点就变得不那么令人信服了。</blockquote></p><p> The chart below shows the one-month performance of AAPL against QQQ over the past decade. Notice that the stock rarely beats the benchmark over such a short period of time by as much as it has in the past 4 to 5 weeks. The last time that it did, in August of last year, marked a peak in price of $134 that Apple stock still traded at until as recently as June 2021.</p><p><blockquote>下图显示了过去十年AAPL与QQQ的一个月表现。请注意，该股很少像过去4到5周那样在如此短的时间内跑赢基准。上一次这样做是在去年8月，当时苹果股票的交易价格达到了134美元的峰值，直到2021年6月。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fb283ad281bad9a0c0b1503520c823e3\" tg-width=\"787\" tg-height=\"468\" width=\"100%\" height=\"auto\"><span>Figure 2: 1-month performance: AAPL vs. QQQ.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：1个月表现：AAPL与QQQ。</span></p></blockquote></p><p> <b>So, will AAPL tank next?</b></p><p><blockquote><b>那么，苹果接下来会崩溃吗？</b></blockquote></p><p> To be crystal clear, none of the above means that Apple stock will likely nosedive in the foreseeable future. But think of investing like a game of blackjack. A player will certainly want to stand at 20 if the dealer’s up card is a 5, for example. Does it mean that, by doing so, the player is guaranteed to win that hand? No, it only means that the odds favor him or her.</p><p><blockquote>需要明确的是，上述情况并不意味着苹果股价在可预见的未来可能会暴跌。但是把投资想象成一场21点游戏。例如，如果庄家的向上牌是5，玩家肯定会想站在20。这是否意味着，通过这样做，玩家一定会赢得那手牌？不，这只意味着胜算对他或她有利。</blockquote></p><p> Likewise, buying Apple when the stock has handily outperformed the Nasdaq over the previous month has historically been disadvantageous. For example: over the past decade, AAPL has produced average one-year returns of +29%, assuming the stock is bought on any random day.</p><p><blockquote>同样，当苹果股票在过去一个月轻松跑赢纳斯达克时买入该股历来是不利的。例如：在过去十年中，假设在任意一天购买该股票，AAPL的平均一年回报率为+29%。</blockquote></p><p> However, this number would have been much lower if shares were bought on strength against the Nasdaq: only +8%, on average, following one-month outperformance of 10% or more against the benchmark. On the other end of the spectrum, average one-year return in AAPL would have been a much better +39% following one-month underperformance of -10% or worse against QQQ.</p><p><blockquote>然而，如果针对纳斯达克强势买入股票，这个数字会低得多：在一个月的表现优于基准10%或更多之后，平均仅+8%。另一方面，在QQQ一个月表现不佳-10%或更差之后，AAPL的平均一年回报率会好得多，为+39%。</blockquote></p><p> The observations above are consistent with&nbsp;the strategy of buying a stock on weakness&nbsp;to take advantage of an eventual rebound; and selling it on strength to lock in gains, some of which could have been produced by irrational bullishness.</p><p><blockquote>上述观察与逢低买入股票以利用最终反弹的策略是一致的；并强势抛售以锁定收益，其中一些收益可能是由非理性看涨产生的。</blockquote></p><p> <b>Panic and sell AAPL?</b></p><p><blockquote><b>恐慌并出售AAPL？</b></blockquote></p><p> At this point, I should reemphasize that I remain an Apple bull. I would not sell all my stake in the company only because the share price climbed from $150 to $180 as quickly as it has.</p><p><blockquote>在这一点上，我应该再次强调，我仍然是苹果多头。我不会仅仅因为股价从150美元迅速攀升至180美元就出售我在该公司的所有股份。</blockquote></p><p> However, I believe that now is a good time to think about rebalancing the portfolio. It seems prudent to me, following the recent rally, that some AAPL trimming and reallocation into other high-quality names would take place during this moment of strength in the stock.</p><p><blockquote>然而，我认为现在是考虑重新平衡投资组合的好时机。在我看来，在最近的反弹之后，在该股走强的时刻，苹果公司将进行一些削减并重新分配到其他高质量的股票中，这似乎是谨慎的。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/apple/stock/apple-stock-it-could-make-sense-to-trim-the-position\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-it-could-make-sense-to-trim-the-position","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199650124","content_text":"Apple stock could be a compelling long-term “buy and hold” play. However, the vicious rally of the past month may also mean that now is a good time to lock in some gains.\nApple stock’s recent run has been impressive. Shares traded at nearly $180 in after-hours on Friday, December 10. If the stock price reaches $181.68 soon, per my estimates, Apple will have become the first company ever to be valued at $3 trillion.\nAmid investor enthusiasm, however, I fear that AAPL may have moved too fast since mid-November. With the stock having outperformed the tech-rich Nasdaq index by a whopping 19.5 percentage points in the past month, could now be a good time to trim the position and lock in some gains?\nFigure 1: Apple store in New York, NY.\nAAPL: impressive returns raise a flag\nTo start, I should make one thing very clear: in my opinion, Apple stock is a compelling long-term “buy and hold” play. In fact, I think that most growth-biased portfolios should be heavily exposed to shares of the Cupertino company, which I believe will outperform the rest of the market over the next, say, decade at least.\nThat said, I like to keep tabs on short term price behavior as well. After plugging in the numbers, I was astonished to see that AAPL has topped the performance of the Nasdaq (QQQ) over a one-month period by the most since late August 2020: outperformance of +19.5%. For the past decade, AAPL’s December 2021 rally vs. the benchmark has been the second strongest.\nLooking into the rearview mirror, this is great news for Apple shareholders. However, one should invest looking into the future. And that’s when the argument for buying Apple stock at $180 apiece today becomes a bit less compelling.\nThe chart below shows the one-month performance of AAPL against QQQ over the past decade. Notice that the stock rarely beats the benchmark over such a short period of time by as much as it has in the past 4 to 5 weeks. The last time that it did, in August of last year, marked a peak in price of $134 that Apple stock still traded at until as recently as June 2021.\nFigure 2: 1-month performance: AAPL vs. QQQ.\nSo, will AAPL tank next?\nTo be crystal clear, none of the above means that Apple stock will likely nosedive in the foreseeable future. But think of investing like a game of blackjack. A player will certainly want to stand at 20 if the dealer’s up card is a 5, for example. Does it mean that, by doing so, the player is guaranteed to win that hand? No, it only means that the odds favor him or her.\nLikewise, buying Apple when the stock has handily outperformed the Nasdaq over the previous month has historically been disadvantageous. For example: over the past decade, AAPL has produced average one-year returns of +29%, assuming the stock is bought on any random day.\nHowever, this number would have been much lower if shares were bought on strength against the Nasdaq: only +8%, on average, following one-month outperformance of 10% or more against the benchmark. On the other end of the spectrum, average one-year return in AAPL would have been a much better +39% following one-month underperformance of -10% or worse against QQQ.\nThe observations above are consistent with the strategy of buying a stock on weakness to take advantage of an eventual rebound; and selling it on strength to lock in gains, some of which could have been produced by irrational bullishness.\nPanic and sell AAPL?\nAt this point, I should reemphasize that I remain an Apple bull. I would not sell all my stake in the company only because the share price climbed from $150 to $180 as quickly as it has.\nHowever, I believe that now is a good time to think about rebalancing the portfolio. It seems prudent to me, following the recent rally, that some AAPL trimming and reallocation into other high-quality names would take place during this moment of strength in the stock.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":1056,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604100520,"gmtCreate":1639356073497,"gmtModify":1639361237744,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604100520","repostId":"1167745509","repostType":4,"repost":{"id":"1167745509","kind":"news","pubTimestamp":1639354221,"share":"https://www.laohu8.com/m/news/1167745509?lang=zh_CN&edition=full","pubTime":"2021-12-13 08:10","market":"sg","language":"en","title":"Singapore Stock Market Poised To Bounce Higher On Monday<blockquote>新加坡股市周一有望反弹走高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1167745509","media":"RTTNews","summary":"The Singapore stock market has finished lower in two of three trading days since the end of the thre","content":"<p>The Singapore stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just above the 3,135-point plateau although it's likely to see renewed support on Monday.</p><p><blockquote>自结束连续三天上涨近45点或1.4%以来，新加坡股市在三个交易日中有两个交易日收低。海峡时报指数目前略高于3,135点的高位，尽管周一可能会再次获得支撑。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed to higher on easing virus concerns and support from crude oil. The European markets were down and the U.S. bourses were up and the Asian markets are tipped to follow the latter lead.</p><p><blockquote>由于病毒担忧缓解和原油支撑，全球对亚洲市场的预测好坏参半。欧洲市场下跌，美国股市上涨，亚洲市场可能会追随后者的脚步。</blockquote></p><p> The STI finished slightly lower on Friday following mixed performances from the financial shares, property stocks and industrial issues.</p><p><blockquote>金融股、房地产股和工业股表现好坏参半，海指周五小幅收低。</blockquote></p><p> For the day, the index slipped 6.84 points or 0.22 percent to finish at 3,135.61 after trading between 3,129.25 and 3,141.85. Volume was 1.86 billion shares worth 863.8 million Singapore dollars. There were 258 decliners and 199 gainers,</p><p><blockquote>当天，该指数在3,129.25点至3,141.85点之间交易后，下跌6.84点或0.22%，收于3,135.61点。成交量为18.6亿股，价值8.638亿新元。下跌股258家，上涨股199家，</blockquote></p><p> Among the actives, Ascendas REIT shed 0.34 percent, while CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.49 percent, City Developments skidded 0.57 percent, Comfort DelGro tanked 1.42 percent, Dairy Farm International retreated 0.66 percent, DBS Group dipped 0.16 percent, Genting Singapore climbed 0.64 percent, Hongkong Land tumbled 1.08 percent, Keppel Corp gained 0.38 percent, Mapletree Logistics Trust advanced 0.53 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS declined 0.76 percent, SembCorp Industries added 0.50 percent, Singapore Airlines plummeted 2.37 percent, Singapore Exchange eased 0.11 percent, Singapore Press Holdings sank 0.43 percent, Singapore Technologies Engineering fell 0.26 percent, SingTel dropped 0.41 percent, Thai Beverage plunged 1.48 percent, United Overseas Bank lost 0.33 percent, Wilmar International surrendered 0.95 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托和丰树商业信托均下跌0.49%，City Developments下跌0.57%，Comfort DelGro下跌1.42%，Dairy Farm International下跌0.66%，星展集团下跌0.16%，云顶新加坡上涨0.64%，香港置地下跌1.08%，吉宝企业上涨0.38%，丰树物流信托上涨0.53%，华侨银行上涨0.09%，胜科工业上涨0.50%，新加坡航空暴跌2.37%，新加坡报业控股下跌0.43%，新加坡电信下跌0.41%，泰国饮料下跌0.48%，大华银行下跌0.33%，丰业国际下跌0.95%，扬子江造船持平。</blockquote></p><p> The lead from Wall Street is positive as the major averages opened higher on Friday, ebbed towards the break but rebounded to finish firmly higher.</p><p><blockquote>华尔街的领先是积极的，主要股指周五开盘走高，在突破时有所回落，但反弹并坚定走高。</blockquote></p><p> The Dow jumped 216.30 points or 0.60 percent to finish at 35.970.99, while the NASDAQ climbed 113.23 points or 0.73 percent to end at 15,630.60 and the S&amp;P 500 gained 44.57 points or 0.95 percent to close at 4,712.02. For the week, the Dow spiked 4 percent, the NASDAQ climbed 3.6 percent and the S&amp;P jumped 3.8 percent.</p><p><blockquote>道琼斯指数上涨216.30点或0.60%，收于35.970.99点；纳斯达克上涨113.23点或0.73%，收于15,630.60点；标普500上涨44.57点或0.95%，收于4,712.02点。本周，道琼斯指数飙升4%，纳斯达克上涨3.6%，标准普尔指数上涨3.8%。</blockquote></p><p> The strength on Wall Street came even after the Labor Department released a report showing U.S. consumer prices surged at the fastest annual rate of in nearly 40 years in November.</p><p><blockquote>尽管美国劳工部发布报告显示，11月份美国消费者价格以近40年来最快的年增长率飙升，但华尔街仍走强。</blockquote></p><p> While the elevated rate of inflation may lead the Federal Reserve to accelerate the pace of tapering its asset purchases next week, traders seemed relieved that the price growth was not even faster.</p><p><blockquote>尽管通胀率上升可能导致美联储下周加快缩减资产购买的步伐，但交易员似乎对价格增长没有更快感到欣慰。</blockquote></p><p> A separate report from the University of Michigan showed consumer sentiment in the U.S. unexpectedly improved in early December.</p><p><blockquote>密歇根大学的另一份报告显示，12月初美国消费者信心意外改善。</blockquote></p><p> Crude oil futures settled higher Friday on easing worries about the Omicron&nbsp;coronavirus&nbsp;variant's impact on global economic growth. West Texas Intermediate Crude oil futures for January ended higher by $0.73 or 1 percent at $71.67 a barrel. WTI crude futures gained 8.2 percent in the week, the best weekly returns since end August.</p><p><blockquote>由于对奥密克戎冠状病毒变种对全球经济增长影响的担忧有所缓解，原油期货周五收高。西德克萨斯中质原油1月期货收高0.73美元或1%，报每桶71.67美元。WTI原油期货本周上涨8.2%，创8月底以来最佳周回报率。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Poised To Bounce Higher On Monday<blockquote>新加坡股市周一有望反弹走高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Poised To Bounce Higher On Monday<blockquote>新加坡股市周一有望反弹走高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-13 08:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just above the 3,135-point plateau although it's likely to see renewed support on Monday.</p><p><blockquote>自结束连续三天上涨近45点或1.4%以来，新加坡股市在三个交易日中有两个交易日收低。海峡时报指数目前略高于3,135点的高位，尽管周一可能会再次获得支撑。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed to higher on easing virus concerns and support from crude oil. The European markets were down and the U.S. bourses were up and the Asian markets are tipped to follow the latter lead.</p><p><blockquote>由于病毒担忧缓解和原油支撑，全球对亚洲市场的预测好坏参半。欧洲市场下跌，美国股市上涨，亚洲市场可能会追随后者的脚步。</blockquote></p><p> The STI finished slightly lower on Friday following mixed performances from the financial shares, property stocks and industrial issues.</p><p><blockquote>金融股、房地产股和工业股表现好坏参半，海指周五小幅收低。</blockquote></p><p> For the day, the index slipped 6.84 points or 0.22 percent to finish at 3,135.61 after trading between 3,129.25 and 3,141.85. Volume was 1.86 billion shares worth 863.8 million Singapore dollars. There were 258 decliners and 199 gainers,</p><p><blockquote>当天，该指数在3,129.25点至3,141.85点之间交易后，下跌6.84点或0.22%，收于3,135.61点。成交量为18.6亿股，价值8.638亿新元。下跌股258家，上涨股199家，</blockquote></p><p> Among the actives, Ascendas REIT shed 0.34 percent, while CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.49 percent, City Developments skidded 0.57 percent, Comfort DelGro tanked 1.42 percent, Dairy Farm International retreated 0.66 percent, DBS Group dipped 0.16 percent, Genting Singapore climbed 0.64 percent, Hongkong Land tumbled 1.08 percent, Keppel Corp gained 0.38 percent, Mapletree Logistics Trust advanced 0.53 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS declined 0.76 percent, SembCorp Industries added 0.50 percent, Singapore Airlines plummeted 2.37 percent, Singapore Exchange eased 0.11 percent, Singapore Press Holdings sank 0.43 percent, Singapore Technologies Engineering fell 0.26 percent, SingTel dropped 0.41 percent, Thai Beverage plunged 1.48 percent, United Overseas Bank lost 0.33 percent, Wilmar International surrendered 0.95 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托和丰树商业信托均下跌0.49%，City Developments下跌0.57%，Comfort DelGro下跌1.42%，Dairy Farm International下跌0.66%，星展集团下跌0.16%，云顶新加坡上涨0.64%，香港置地下跌1.08%，吉宝企业上涨0.38%，丰树物流信托上涨0.53%，华侨银行上涨0.09%，胜科工业上涨0.50%，新加坡航空暴跌2.37%，新加坡报业控股下跌0.43%，新加坡电信下跌0.41%，泰国饮料下跌0.48%，大华银行下跌0.33%，丰业国际下跌0.95%，扬子江造船持平。</blockquote></p><p> The lead from Wall Street is positive as the major averages opened higher on Friday, ebbed towards the break but rebounded to finish firmly higher.</p><p><blockquote>华尔街的领先是积极的，主要股指周五开盘走高，在突破时有所回落，但反弹并坚定走高。</blockquote></p><p> The Dow jumped 216.30 points or 0.60 percent to finish at 35.970.99, while the NASDAQ climbed 113.23 points or 0.73 percent to end at 15,630.60 and the S&amp;P 500 gained 44.57 points or 0.95 percent to close at 4,712.02. For the week, the Dow spiked 4 percent, the NASDAQ climbed 3.6 percent and the S&amp;P jumped 3.8 percent.</p><p><blockquote>道琼斯指数上涨216.30点或0.60%，收于35.970.99点；纳斯达克上涨113.23点或0.73%，收于15,630.60点；标普500上涨44.57点或0.95%，收于4,712.02点。本周，道琼斯指数飙升4%，纳斯达克上涨3.6%，标准普尔指数上涨3.8%。</blockquote></p><p> The strength on Wall Street came even after the Labor Department released a report showing U.S. consumer prices surged at the fastest annual rate of in nearly 40 years in November.</p><p><blockquote>尽管美国劳工部发布报告显示，11月份美国消费者价格以近40年来最快的年增长率飙升，但华尔街仍走强。</blockquote></p><p> While the elevated rate of inflation may lead the Federal Reserve to accelerate the pace of tapering its asset purchases next week, traders seemed relieved that the price growth was not even faster.</p><p><blockquote>尽管通胀率上升可能导致美联储下周加快缩减资产购买的步伐，但交易员似乎对价格增长没有更快感到欣慰。</blockquote></p><p> A separate report from the University of Michigan showed consumer sentiment in the U.S. unexpectedly improved in early December.</p><p><blockquote>密歇根大学的另一份报告显示，12月初美国消费者信心意外改善。</blockquote></p><p> Crude oil futures settled higher Friday on easing worries about the Omicron&nbsp;coronavirus&nbsp;variant's impact on global economic growth. West Texas Intermediate Crude oil futures for January ended higher by $0.73 or 1 percent at $71.67 a barrel. WTI crude futures gained 8.2 percent in the week, the best weekly returns since end August.</p><p><blockquote>由于对奥密克戎冠状病毒变种对全球经济增长影响的担忧有所缓解，原油期货周五收高。西德克萨斯中质原油1月期货收高0.73美元或1%，报每桶71.67美元。WTI原油期货本周上涨8.2%，创8月底以来最佳周回报率。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3248605/singapore-stock-market-poised-to-bounce-higher-on-monday.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3248605/singapore-stock-market-poised-to-bounce-higher-on-monday.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167745509","content_text":"The Singapore stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just above the 3,135-point plateau although it's likely to see renewed support on Monday.\nThe global forecast for the Asian markets is mixed to higher on easing virus concerns and support from crude oil. The European markets were down and the U.S. bourses were up and the Asian markets are tipped to follow the latter lead.\nThe STI finished slightly lower on Friday following mixed performances from the financial shares, property stocks and industrial issues.\nFor the day, the index slipped 6.84 points or 0.22 percent to finish at 3,135.61 after trading between 3,129.25 and 3,141.85. Volume was 1.86 billion shares worth 863.8 million Singapore dollars. There were 258 decliners and 199 gainers,\nAmong the actives, Ascendas REIT shed 0.34 percent, while CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.49 percent, City Developments skidded 0.57 percent, Comfort DelGro tanked 1.42 percent, Dairy Farm International retreated 0.66 percent, DBS Group dipped 0.16 percent, Genting Singapore climbed 0.64 percent, Hongkong Land tumbled 1.08 percent, Keppel Corp gained 0.38 percent, Mapletree Logistics Trust advanced 0.53 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS declined 0.76 percent, SembCorp Industries added 0.50 percent, Singapore Airlines plummeted 2.37 percent, Singapore Exchange eased 0.11 percent, Singapore Press Holdings sank 0.43 percent, Singapore Technologies Engineering fell 0.26 percent, SingTel dropped 0.41 percent, Thai Beverage plunged 1.48 percent, United Overseas Bank lost 0.33 percent, Wilmar International surrendered 0.95 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is positive as the major averages opened higher on Friday, ebbed towards the break but rebounded to finish firmly higher.\nThe Dow jumped 216.30 points or 0.60 percent to finish at 35.970.99, while the NASDAQ climbed 113.23 points or 0.73 percent to end at 15,630.60 and the S&P 500 gained 44.57 points or 0.95 percent to close at 4,712.02. For the week, the Dow spiked 4 percent, the NASDAQ climbed 3.6 percent and the S&P jumped 3.8 percent.\nThe strength on Wall Street came even after the Labor Department released a report showing U.S. consumer prices surged at the fastest annual rate of in nearly 40 years in November.\nWhile the elevated rate of inflation may lead the Federal Reserve to accelerate the pace of tapering its asset purchases next week, traders seemed relieved that the price growth was not even faster.\nA separate report from the University of Michigan showed consumer sentiment in the U.S. unexpectedly improved in early December.\nCrude oil futures settled higher Friday on easing worries about the Omicron coronavirus variant's impact on global economic growth. West Texas Intermediate Crude oil futures for January ended higher by $0.73 or 1 percent at $71.67 a barrel. WTI crude futures gained 8.2 percent in the week, the best weekly returns since end August.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":1033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604058912,"gmtCreate":1639287409238,"gmtModify":1639287409387,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604058912","repostId":"2190679207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605274728,"gmtCreate":1639186023357,"gmtModify":1639189306738,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Yipee","listText":"Yipee","text":"Yipee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605274728","repostId":"2190767366","repostType":4,"isVote":1,"tweetType":1,"viewCount":1419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605932194,"gmtCreate":1639100308547,"gmtModify":1639100308644,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/605932194","repostId":"2190964556","repostType":4,"isVote":1,"tweetType":1,"viewCount":1116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602615563,"gmtCreate":1639014195046,"gmtModify":1639014195143,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602615563","repostId":"1193274987","repostType":4,"isVote":1,"tweetType":1,"viewCount":1026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":822943133,"gmtCreate":1634087379188,"gmtModify":1634087952798,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"[流泪]&nbsp;","listText":"[流泪]&nbsp;","text":"[流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/822943133","repostId":"2175132100","repostType":4,"isVote":1,"tweetType":1,"viewCount":644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069609,"gmtCreate":1640576292644,"gmtModify":1640576340157,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696069609","repostId":"2194380177","repostType":4,"isVote":1,"tweetType":1,"viewCount":2599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":804877909,"gmtCreate":1627951975701,"gmtModify":1631889896623,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/804877909","repostId":"2156114224","repostType":4,"isVote":1,"tweetType":1,"viewCount":603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":877374047,"gmtCreate":1637893206563,"gmtModify":1637893206563,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Good progress","listText":"Good progress","text":"Good progress","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/877374047","repostId":"1172101126","repostType":4,"repost":{"id":"1172101126","kind":"news","pubTimestamp":1637892884,"share":"https://www.laohu8.com/m/news/1172101126?lang=zh_CN&edition=full","pubTime":"2021-11-26 10:14","market":"us","language":"en","title":"Novavax: Some Burning Questions<blockquote>Novavax：一些紧迫的问题</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172101126","media":"Seeking Alpha","summary":"Summary\n\nNovavax is making good progress with SII backed regulatory filings.\nSII and the Indian gove","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Novavax is making good progress with SII backed regulatory filings.</li>  <li>SII and the Indian government “ban” on COVID vaccine exports are a necessary vulnerability in the short term.</li>  <li>Investors cannot have tunnel vision on SII and Novavax must urgently provide answers on manufacturing, stockpiles, and shipments.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2494454304cd81dfbde9de88defac732\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Maria Golenishcheva/iStock via Getty Images</span></p><p><blockquote><ul><li>Novavax在SII支持的监管文件方面取得了良好进展。</li><li>SII和印度政府对COVID疫苗出口的“禁令”是短期内必要的漏洞。</li><li>投资者不能对SII抱有狭隘的看法，Novavax必须紧急提供有关制造、库存和运输的答案。</li></ul><p class=\"t-img-caption\"><span>Maria Golenishcheva/iStock来自Getty Images</span></p></blockquote></p><p> Novavax(NASDAQ:NVAX)has announced its intention to participate in a Fireside Chat at&nbsp;Evercore&nbsp;ISI's 4th Annual HealthCONx Virtual Conference on 2 December 2021. This is the first event at which Novavax will participate since the&nbsp;Earnings Call(EC)on 4 November 2021.BioNTech(NASDAQ:BNTX)&nbsp;has participated in 3 events since their EC on 9 Nov including the Jefferies London Healthcare Conference and will also participate in the Evercore event.Moderna(NASDAQ:MRNA)&nbsp;also has participated in 3 events since their EC on 4 Nov and have announced participation in two more before 2 Dec but has not yet advised if they will be attending Evercore. Participating at events provide investors with general information. Novavax's absence form events in November has left a lot of questions unanswered.</p><p><blockquote>Novavax（纳斯达克：NVAX）宣布有意参加2021年12月2日Evercore ISI第四届年度HealthCONx虚拟会议的炉边谈话。这是Novavax自2021年11月4日看涨期权(EC)以来参加的首次活动。BioNTech（纳斯达克：BNTX）自11月9日EC以来已参加了3场活动，包括Jefferies London Healthcare Conference，并将参加Evercore活动。Moderna（纳斯达克：MRNA）自11月4日EC以来也参加了3场活动，并宣布在12月2日之前参加另外两场活动，但尚未告知他们是否会参加Evercore。参加活动为投资者提供一般信息。Novavax缺席11月份的活动留下了许多悬而未决的问题。</blockquote></p><p> Novavax has announced the following successes since the EC:</p><p><blockquote>自EC以来，Novavax已宣布取得以下成功：</blockquote></p><p> <ul>  <li>Submission of Biologics License Application in&nbsp;South Korea&nbsp;for Approval of NVX-CoV2373.</li>  <li>Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the&nbsp;Philippines.</li>  <li>Novavax Confirms&nbsp;European Medicines Agency&nbsp;Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization.</li>  <li>Novavax Files for Interim Authorization of COVID-19 Vaccine in&nbsp;Singapore.</li> </ul> The Novavax progress continues but at the same time the vacuum of information on manufacturing and delivery remains. It is important to discuss the burning questions and the lack of information on manufacturing, stockpile, and delivery.</p><p><blockquote><ul><li>在韩国提交生物制品许可申请以批准NVX-CoV2373。</li><li>Novavax和印度血清研究所获得新冠肺炎疫苗在菲律宾的紧急使用授权。</li><li>Novavax确认欧洲药品管理局对新冠肺炎疫苗有条件上市许可申请的审查。</li><li>Novavax在新加坡申请新冠肺炎疫苗的临时授权。</li></ul>Novavax的进展仍在继续，但与此同时，有关制造和交付的信息真空仍然存在。讨论紧迫的问题以及缺乏关于制造、库存和交付的信息是很重要的。</blockquote></p><p> None of the recent notices made specific reference to manufacturing or delivery. The notice on the Philippines is not clear on whether SII will be delivering vaccine doses to the Philippines at all or whether SII must first construct a manufacturing facility in the Philippines from which vaccines will be delivered. The statement reads, “The vaccine will be manufactured and marketed in the Philippines by SII under the brand name COVOVAX™.” Why this wording “manufactured and marketed in the Philippines”? Was it just clumsy or not? The Philippines announced an intention in March 2021 to partner with SII for manufacturing in the Philippines.</p><p><blockquote>最近的通知都没有具体提到制造或交付。关于菲律宾的通知不清楚SII是否会向菲律宾运送疫苗，或者SII是否必须首先在菲律宾建造一个生产设施，从那里运送疫苗。声明中写道，“该疫苗将由SII以COVOVAX品牌在菲律宾生产和销售。”™为什么是“在菲律宾制造和销售”？是不是很笨拙？菲律宾于2021年3月宣布有意与SII合作在菲律宾进行制造。</blockquote></p><p>   “PH eyes&nbsp;local vaccine production&nbsp;with Serum Institute of India” March 17, 2021.  India has a general “restriction” on the export of COVID vaccines from India. It’s an unofficial “ban” on exports which are only allowed with government of India approval. It is also disconcerting that the application for approval of the Novavax vaccine has been&nbsp;submitted to India&nbsp;already on 5 August 2021 and it has not yet been approved by India.</p><p><blockquote>“PH关注印度血清研究所的本地疫苗生产”2021年3月17日。印度对从印度出口COVID疫苗有普遍的“限制”。这是一项非官方的出口“禁令”，只有在印度政府批准的情况下才允许。同样令人不安的是，Novavax疫苗的批准申请已于2021年8月5日提交给印度，但尚未获得印度的批准。</blockquote></p><p>   “He, however, clarified there was no ban on vaccine exports as neither the health ministry, commerce and industry ministry, department of promotion of industry and internal trade, nor the directorate general of foreign trade has issued any formal orders asking to bar the export of COVID-19 vaccines from the country.”COVID vaccines’ export&nbsp;may not resume before 2022.  Digging in news reports on deliveries to Indonesia indicate delivery of 20mil doses by the end of Dec 2021.Reuters&nbsp;reported on 18 November that, “India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source”.Shipment&nbsp;is likely to happen towards the end of next month, one of the sources said. Further reporting has SII potentially producing&nbsp;up to 100mil&nbsp;doses by the end of Dec 2021.</p><p><blockquote>“然而，他澄清说，没有禁止疫苗出口，因为卫生部、商业和工业部、工业和国内贸易部以及外贸总局都没有发布任何正式命令，要求禁止从该国出口新冠肺炎疫苗。”COVID疫苗的出口可能不会在2022年之前恢复。挖掘关于向印度尼西亚交付的新闻报道表明，到2021年12月底，将交付2000万剂疫苗。路透社11月18日报道称，“印度允许向印度尼西亚出口2000万剂Novavax疫苗——文件，来源”。其中一位消息人士称，发货可能会在下月底进行。进一步报告称，到2021年12月底，SII可能会生产多达1亿剂疫苗。</blockquote></p><p> The very bullish investment thesis for Novavax is still intact but investors cannot be expected to have tunnel vision on SII. Investors need quality communication from Novavax to maintain that investment thesis. The vacuum of information on the big picture for manufacturing, stockpiles, shipments, revenue, and income encourages wild speculation and rumor mongering.</p><p><blockquote>Novavax非常乐观的投资论点仍然完好无损，但不能指望投资者对SII有狭隘的看法。投资者需要Novavax的高质量沟通来维持这一投资论点。关于制造、库存、运输、收入和收入的信息真空鼓励了疯狂的猜测和谣言传播。</blockquote></p><p> <b>Burning Questions around Manufacturing, Stockpile and Shipments.</b></p><p><blockquote><b>围绕制造、库存和运输的紧迫问题。</b></blockquote></p><p></p><p> No amount of digging could provide substantiated answers to the following questions which are vital for investors to make informed decisions on investing in Novavax shares. Investors are forced to infer or speculate on the answers to many of these questions in the absence of facts. Perhaps some of these questions will be answered in the Fireside Chat with Evercore. Perhaps Novavax will become more forthcoming about its activities, but investors are desperate for reliable information. Most companies go out of their way to sit down with analysts and give them quality information empowering them to achieve the same outcomes as the guidance of the company. Novavax has been skirting the questions around manufacturing, stockpiles and shipments and it has become pressing for investors to have reliable information.</p><p><blockquote>再多的挖掘也无法为以下问题提供确凿的答案，这些问题对于投资者在投资Novavax股票时做出明智的决策至关重要。在缺乏事实的情况下，投资者被迫推断或推测其中许多问题的答案。也许其中一些问题会在与Evercore的炉边谈话中得到解答。也许Novavax会更加公开其活动，但投资者迫切需要可靠的信息。大多数公司都会特意与分析师坐下来，向他们提供高质量的信息，使他们能够实现与公司指导相同的结果。Novavax一直回避有关制造、库存和运输的问题，投资者迫切需要获得可靠的信息。</blockquote></p><p> The questions which follows can't be answered from available information. Investors are at risk in the absence of the information which should be readily available to be packaged for investors. Each question will be followed by an explanation why the information is important.</p><p><blockquote>接下来的问题无法从现有信息中回答。由于缺乏本应随时为投资者打包的信息，投资者面临风险。每个问题之后都会解释为什么这些信息很重要。</blockquote></p><p> <b>Manufacturing Questions</b></p><p><blockquote><b>制造问题</b></blockquote></p><p></p><p> <ol>  <li>Why has no other manufacturing facility, particularly the Novavax specific facilities, been submitted yet? Importance: Novavax was following a holistic approach towards achieving regulatory approval for all its manufacturing facilities up to the point when the&nbsp;Politico article&nbsp;was published on 19 October 2021. \"...we’ve built a&nbsp;global&nbsp;manufacturing infrastructure over the last year that has a robust eight different antigen manufacturing facilities in seven different countries.\" On 27 October 2021 Novavax filed for authorization of its vaccine in the UK and that filing was narrowed from a \"global manufacturing infrastructure\" to a single manufacturer filing that \"leverages our manufacturing partnership with the&nbsp;Serum Institute of India.In the near future, we expect to supplement this filing with supply from our global supply chain.\" All subsequent regulatory filings since 27 October 2021, other than South Korea were done in the same manner, leveraging SII as manufacturer.</li>  <li>Will all facilities now manufacture components and export them to SII for manufacturing or fill &amp; finish? Importance: Stanley Erck, CEO of Novavax said at the&nbsp;EC: \"And so they (SII) have fill finish capacity that's virtually unlimited. We can make many hundreds of millions of doses per month in their facility. And we've also signed an agreement with them, if we want for them to make product for high income markets. And so we have a CDMO agreement with them. And so they wouldn't supply as finished product, whether in one of two ways either from antigen, these spike protein that they make at Serum, or from spike protein that we make in our various sites around the world.\" The shift to SII seems to also imply greater reliance on the manufacturing capabilities of SII. It is important for investors to understand the implications of this shift.</li>  <li>Can SII export any vaccine doses without approvals from the Indian government? Importance: As indicated above, exports of COVID vaccines from India are presently subject to, at the very least, Indian government approvals. The shift towards utilizing SII manufacturing facilities requires understanding of the potential risk associated with reliance on a single manufacturer and single country.</li>  <li>SII reported communication on manufacturing is materially more conservative than Novavax reports, indicating only up to 100mil doses manufactured by the end of Dec 2021. Why the difference? Importance: John Trizzino said at the&nbsp;EC: \"Looking to the months ahead, we expect to achieve a manufacturing capacity of 150 million doses per month by the end of the fourth quarter.\" SII as quoted above expect to produce up to 100mil doses by the end of Dec 2021. The discrepancy between Novavax and SII is, between 150mil doses per month vs up to 100mil doses by the end of Dec 2021.</li>  <li>How much actual manufacturing of regulatory compliant vaccine doses are taking place at Novavax manufacturing facilities and all partner facilities? Not capacity, actual manufacturing. Importance: Novavax describes manufacturing as \"manufacturing capacity\" (see 4 above). SII indicated production of up to 100mil doses by the end of Dec 2021 and presently is the only manufacturer put forward in regulatory filings. Investors need information on the activities of the other manufacturers in the global manufacturing network to support the investment thesis particularly looking at 2022 and beyond. How and when would they start contributing to actual doses being available for deliveries?</li>  <li>When will all other manufacturing facilities be submitted for regulatory approvals? Importance: All other manufacturing facilities were supposed to have been included in the \"near future\" which is ambiguous. It's one month later and no guidance or filings have been made for any of these facilities.</li>  <li>What is the manufacturing guidance from all facilities say by Q1, Q2, Q3 and full year? Not capacity guidance, actual manufactured doses, regulatory compliant and available for shipment and delivery. Importance: This question follows from 6 above and the guidance is needed to estimate the revenue and income potential for Novavax during those periods. Novavax provided no guidance on full year 2021 or 2022 earnings during the EC.</li>  <li>Investors will need information on manufacturing at the different facilities to allow for reasoned estimates of sales into different regions as well as COVAX. What will be the composition of manufacturing and delivery for low value sales and for high value sales? Importance: Novavax's&nbsp;reported sales&nbsp;prices range from $3 per dose to $21. The allocations of manufactured doses from the various manufacturing facilities are important indicators of the potential revenue which can be expected from those deliveries. It is expected that a material portion of the&nbsp;SII manufacturing&nbsp;will initially go to COVAX and into markets where </p><p><blockquote><ol><li>为什么尚未提交其他生产设施，特别是Novavax特定设施？重要性：在Politico文章于2021年10月19日发表之前，Novavax一直在采取整体方法来获得监管机构的批准。“……去年我们建立了全球制造基础设施，在七个不同的国家拥有强大的八个不同的抗原制造设施。”2021年10月27日，Novavax在英国申请了其疫苗的授权，该申请从“全球制造基础设施”缩小到“利用我们与印度血清研究所的制造合作伙伴关系”的单一制造商申请。在不久的将来，我们预计将通过我们全球供应链的供应来补充该文件。”自2021年10月27日以来，除韩国外，所有后续监管备案均以相同方式完成，利用SII作为制造商。</li><li>所有工厂现在都会制造组件并将其出口到SII进行制造或灌装和精加工吗？重要性：Novavax首席执行官Stanley Erck在欧盟委员会上表示：“因此，他们（SII）拥有几乎无限的灌装能力。我们每个月可以在他们的工厂生产数亿剂。如果我们想让他们为高收入市场生产产品，我们也和他们签署了协议。所以我们和他们有CDMO协议。因此，他们不会作为成品供应，无论是通过两种方式之一，要么来自抗原（他们在血清中制造的刺突蛋白，要么来自我们在世界各地制造的刺突蛋白。”向SII的转变似乎也意味着对SII制造能力的更大依赖。对于投资者来说，理解这一转变的影响非常重要。</li><li>没有印度政府的批准，SII可以出口任何疫苗剂量吗？重要性：如上所述，从印度出口COVID疫苗目前至少需要印度政府的批准。转向利用SII制造设施需要了解与依赖单一制造商和单一国家相关的潜在风险。</li><li>SII报告的关于生产的沟通比Novavax的报告要保守得多，表明到2021年12月底仅生产了多达1亿剂。为什么会有区别？重要性：John Trizzino在EC表示：“展望未来几个月，我们预计到第四季度末将实现每月1.5亿剂的生产能力。”如上所述，SII预计到2021年12月底将生产多达1亿剂疫苗。Novavax和SII之间的差异是，到2021年12月底，每月1.5亿剂与高达1亿剂之间。</li><li>Novavax生产工厂和所有合作伙伴工厂实际生产了多少符合法规的疫苗剂量？不是产能，而是实际制造。重要性：Novavax将制造描述为“制造能力”（见上文4）。SII表示，到2021年12月底，产量将达到1亿剂，目前是唯一一家在监管文件中提出的制造商。投资者需要有关全球制造网络中其他制造商活动的信息，以支持投资论点，特别是着眼于2022年及以后的投资论点。他们将如何以及何时开始为可用于分娩的实际剂量做出贡献？</li><li>所有其他生产设施何时提交监管机构批准？重要性：所有其他制造设施都应该包括在“不久的将来”中，这是模糊的。一个月后，还没有对这些设施进行指导或备案。</li><li>第一季度、第二季度、第三季度和全年所有工厂的制造指导是什么？不是容量指南，实际生产剂量，符合法规，可用于装运和交付。重要性：这个问题来自上面的6个问题，需要指导来估计Novavax在这些时期的收入和收入潜力。Novavax在EC期间没有提供2021年或2022年全年收益指引。</li><li>投资者将需要有关不同工厂生产的信息，以便合理估计不同地区以及COVAX的销售额。低价值销售和高价值销售的制造和交付构成是什么？重要性：Novavax报告的销售价格从每剂3美元到21美元不等。来自各种制造设施的制造剂量的分配是可以从这些交付中预期的潜在收入的重要指标。预计SII制造的重要部分最初将流向COVAX和以下市场：</li></ol></blockquote></p><p></p><p> <ol>  <li>What is the size of the actual stockpile at SII, tens of millions can be 20mil doses or up to 90mil doses, it is far too inexact? Importance: The Novavax CEO answered at the EC: \"Well, I think I answered the second part of the question that SII will be the initial manufacturer. They've already made many 10s of millions of doses that are waiting to be shippable. They're sitting we've -- my team has physically gone over there and touched them.\" The stockpile can theoretically be shipped with immediate effect and generate income still in 2021. The actual size matters.</li>  <li>What is the size of the regulatory compliant stockpile of doses at all facilities combined, again, tens of millions are not exact enough? Importance: The communication at the EC was very fragmented but it seems that there may be inventory other than that at SII. Novavax CEO: \"And for each of these, we're trying to allocate product both that we have in inventory in the U.S. and Europe and South Korea and an inventory that's being built up at Serum...\" Better understanding of regulatory compliant available inventory at all facilities will inform investor expectations on the timing of revenue as well as the expected quantum thereof.</li>  <li>What is the breakdown of the stockpile at the various manufacturing facilities, those able to deliver a finished product? Importance: A breakdown of the stockpile will guide investor expectations regarding potential income from high value deliveries vs low value deliveries and the timing thereof.</li>  <li>There has been rumor that the 20mil dose export from SII was approved because of its expiry date, rumor is not where information should originate from. How dated is the various stockpiles?</li> </ol> <b>Shipment and Delivery Questions</b></p><p><blockquote><ol><li>SII的实际库存有多大，几千万可以是2000万剂，也可以是9000万剂，这太不准确了？重要性：Novavax首席执行官在EC上回答道：“嗯，我想我回答了问题的第二部分，即SII将是最初的制造商。他们已经生产了数千万剂疫苗，正在等待发货。他们坐在那里，我们——我的团队亲自去那里触摸了他们。”理论上，库存可以立即发货，并在2021年仍能产生收入。实际大小很重要。</li><li>所有设施的合规剂量库存加起来有多大，同样，数千万还不够准确？重要性：欧共体的沟通非常分散，但似乎可能有SII以外的库存。Novavax首席执行官：“对于每一种产品，我们都在尝试分配美国、欧洲和韩国库存的产品以及Serum正在建立的库存……”更好地了解所有设施中符合法规的可用库存将告知投资者对收入时间及其预期数量的预期。</li><li>能够交付成品的各种制造设施的库存细目是什么？重要性：库存的细分将指导投资者对高价值交付与低价值交付的潜在收入及其时间的预期。</li><li>有传言说，从SII出口的2000万剂疫苗因其有效期而被批准，谣言不是信息的来源。各种库存有多老？</li></ol><b>装运和交付问题</b></blockquote></p><p> <ol>  <li>Why will the 20mil shipment to Indonesia only take place by the end of Dec 2021 if the doses are available in stockpile right now? Importance: Novavax CEO at the EC: \"We've expect that initial shipments into Indonesia by Serum will begin imminently.\" The guidance of SII on delivery to Indonesia clearly differs from the comment by the CEO of Novavax. This question also has a larger context. How many doses can be expected to be shipped still in 2021 which will translate into revenue and income for the full year results EC in March 2022?</li>  <li>Why only 20mil doses? Importance: SII has tens of millions of doses in stockpile and can manufacture up to 100mil doses be the end of Dec 2021 yet only 20mil doses out of a 50mil doses order by Indonesia are expected to be shipped by end of Dec 2021.</li>  <li>How many doses are SII expected to ship in 2021? Importance: This question follows on q2 above. There are potential doses for shipment from stockpile and from manufacturing yet only 20mil has been reported.</li>  <li>Where will doses be shipped from in 2022, which manufacturing facilities? Importance: The shift in emphasis to SII for the time being raises this question. Which of the other manufacturing facilities in the global manufacturing network will be designated to ship finished product?</li>  <li>How many doses are expected be shipped and delivered in H1 and full year in 2022. Importance: All of the Novavax guidance is \"manufacturing capacity\" which informs investors what the maximum potential production capacity may be, but it does not inform the investor how much actual manufacturing can be expected within a given period, manufactured product which can be delivered under sales agreements.</li>  <li>Why are no shipments to the Philippines scheduled so far? Importance: A tiny shipment of 20mil doses has been reported for Indonesia but no scheduled delivery to the Philippines has been reported so far.</li> </ol> Filing for regulatory approvals in the name of SII as manufacturer surely advances the standing of the Novavax vaccine but it needs to be backed up by manufacturing and an ability to export the vaccines to those countries who had purchased doses. The presence of the Indian government looms large in the manufacturing and shipments of doses from SII. This vulnerability of Novavax to a single supplier/manufacturer must be explored and understood. Yes, the other facilities will in time also contribute, but guidance so far has been that those facilities should have been in play already and they are not. Investors need to understand, why not? When will those facilities contribute regulatory approved doses and contribute to the revenue and income of Novavax?</p><p><blockquote><ol><li>如果现在有库存，为什么2000万剂要到2021年12月底才能向印度尼西亚运送？重要性：Novavax首席执行官在欧盟表示：“我们预计血清将很快开始向印度尼西亚运送。”SII关于向印尼交货的指导与Novavax首席执行官的评论明显不同。这个问题还有一个更大的背景。预计2021年仍有多少剂量将转化为2022年3月全年业绩EC的收入和收入？</li><li>为什么只有2000万剂？重要性：SII有数千万剂库存，到2021年12月底可以生产多达1亿剂，但印度尼西亚订购的5000万剂中只有2000万剂预计到2021年12月底发货。</li><li>SII预计在2021年发货多少剂？重要性：这个问题在上面的q2之后。库存和生产中都有潜在的剂量可供运输，但据报道只有2000万。</li><li>2022年，剂量将从哪里运送，哪些制造设施？重要性：重点暂时转移到SII提出了这个问题。全球制造网络中的哪些其他制造工厂将被指定运送成品？</li><li>预计2022年H1和全年将运送和交付多少剂疫苗。重要性：Novavax的所有指导都是“制造能力”，它告诉投资者最大潜在生产能力是多少，但它没有告诉投资者在给定时期内可以预期多少实际制造，可以根据销售协议交付的制造产品。</li><li>为什么到目前为止还没有计划向菲律宾发货？重要性：据报道，有2000万剂疫苗运往印度尼西亚，但到目前为止，还没有计划运往菲律宾的报道。</li></ol>以SII作为制造商的名义申请监管部门的批准肯定会提高Novavax疫苗的地位，但它需要得到制造和向购买疫苗的国家出口疫苗的能力的支持。在从SII制造和运输剂量方面，印度政府的存在举足轻重。必须探索和理解Novavax对单一供应商/制造商的这种脆弱性。是的，其他设施也将及时做出贡献，但迄今为止的指导是，这些设施应该已经投入使用，但它们没有。投资者需要理解，何乐而不为呢？这些设施何时会贡献监管批准的剂量并为Novavax的收入和收益做出贡献？</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p></p><p> Novavax has made good progress since the&nbsp;Politico&nbsp;article to prove its ability to manufacture and deliver vaccine doses. Concentrating all the filings and all the manufacturing at SII are exposing Novavax to a single source manufacturer/supplier and political risk. The absence of information on manufacturing, stockpiles and shipments have become burning questions for investors. 2021 is almost over and only one shipment for 20mil vaccine doses is scheduled for the end of Dec 2021. It is hoped that Novavax will initiate a process to provide quality information on the burning questions around manufacturing, stockpiles and shipments and perhaps deal with some of it at the Evercore Fireside Chat. Investors require quality information to inform their decisions to buy Novavax shares and hold them based upon an informed investment thesis. The information currently available is lacking in that regard given a significant strategic shift by Novavax since the publication of the Politico article.</p><p><blockquote>自Politico发表文章以来，Novavax取得了良好进展，证明了其生产和提供疫苗剂量的能力。将所有备案和所有生产集中在SII使Novavax面临单一来源制造商/供应商和政治风险。缺乏有关制造、库存和出货量的信息已成为投资者面临的紧迫问题。2021年即将结束，只有一批2000万剂疫苗计划在2021年12月底发货。希望Novavax能够启动一个流程，提供有关制造、库存和运输等紧迫问题的高质量信息，并可能在Evercore炉边谈话中解决其中一些问题。投资者需要高质量的信息来决定购买Novavax股票并根据明智的投资论点持有这些股票。鉴于自Politico文章发表以来Novavax发生了重大战略转变，目前缺乏这方面的信息。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax: Some Burning Questions<blockquote>Novavax：一些紧迫的问题</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax: Some Burning Questions<blockquote>Novavax：一些紧迫的问题</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-11-26 10:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Novavax is making good progress with SII backed regulatory filings.</li>  <li>SII and the Indian government “ban” on COVID vaccine exports are a necessary vulnerability in the short term.</li>  <li>Investors cannot have tunnel vision on SII and Novavax must urgently provide answers on manufacturing, stockpiles, and shipments.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2494454304cd81dfbde9de88defac732\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Maria Golenishcheva/iStock via Getty Images</span></p><p><blockquote><ul><li>Novavax在SII支持的监管文件方面取得了良好进展。</li><li>SII和印度政府对COVID疫苗出口的“禁令”是短期内必要的漏洞。</li><li>投资者不能对SII抱有狭隘的看法，Novavax必须紧急提供有关制造、库存和运输的答案。</li></ul><p class=\"t-img-caption\"><span>Maria Golenishcheva/iStock来自Getty Images</span></p></blockquote></p><p> Novavax(NASDAQ:NVAX)has announced its intention to participate in a Fireside Chat at&nbsp;Evercore&nbsp;ISI's 4th Annual HealthCONx Virtual Conference on 2 December 2021. This is the first event at which Novavax will participate since the&nbsp;Earnings Call(EC)on 4 November 2021.BioNTech(NASDAQ:BNTX)&nbsp;has participated in 3 events since their EC on 9 Nov including the Jefferies London Healthcare Conference and will also participate in the Evercore event.Moderna(NASDAQ:MRNA)&nbsp;also has participated in 3 events since their EC on 4 Nov and have announced participation in two more before 2 Dec but has not yet advised if they will be attending Evercore. Participating at events provide investors with general information. Novavax's absence form events in November has left a lot of questions unanswered.</p><p><blockquote>Novavax（纳斯达克：NVAX）宣布有意参加2021年12月2日Evercore ISI第四届年度HealthCONx虚拟会议的炉边谈话。这是Novavax自2021年11月4日看涨期权(EC)以来参加的首次活动。BioNTech（纳斯达克：BNTX）自11月9日EC以来已参加了3场活动，包括Jefferies London Healthcare Conference，并将参加Evercore活动。Moderna（纳斯达克：MRNA）自11月4日EC以来也参加了3场活动，并宣布在12月2日之前参加另外两场活动，但尚未告知他们是否会参加Evercore。参加活动为投资者提供一般信息。Novavax缺席11月份的活动留下了许多悬而未决的问题。</blockquote></p><p> Novavax has announced the following successes since the EC:</p><p><blockquote>自EC以来，Novavax已宣布取得以下成功：</blockquote></p><p> <ul>  <li>Submission of Biologics License Application in&nbsp;South Korea&nbsp;for Approval of NVX-CoV2373.</li>  <li>Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the&nbsp;Philippines.</li>  <li>Novavax Confirms&nbsp;European Medicines Agency&nbsp;Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization.</li>  <li>Novavax Files for Interim Authorization of COVID-19 Vaccine in&nbsp;Singapore.</li> </ul> The Novavax progress continues but at the same time the vacuum of information on manufacturing and delivery remains. It is important to discuss the burning questions and the lack of information on manufacturing, stockpile, and delivery.</p><p><blockquote><ul><li>在韩国提交生物制品许可申请以批准NVX-CoV2373。</li><li>Novavax和印度血清研究所获得新冠肺炎疫苗在菲律宾的紧急使用授权。</li><li>Novavax确认欧洲药品管理局对新冠肺炎疫苗有条件上市许可申请的审查。</li><li>Novavax在新加坡申请新冠肺炎疫苗的临时授权。</li></ul>Novavax的进展仍在继续，但与此同时，有关制造和交付的信息真空仍然存在。讨论紧迫的问题以及缺乏关于制造、库存和交付的信息是很重要的。</blockquote></p><p> None of the recent notices made specific reference to manufacturing or delivery. The notice on the Philippines is not clear on whether SII will be delivering vaccine doses to the Philippines at all or whether SII must first construct a manufacturing facility in the Philippines from which vaccines will be delivered. The statement reads, “The vaccine will be manufactured and marketed in the Philippines by SII under the brand name COVOVAX™.” Why this wording “manufactured and marketed in the Philippines”? Was it just clumsy or not? The Philippines announced an intention in March 2021 to partner with SII for manufacturing in the Philippines.</p><p><blockquote>最近的通知都没有具体提到制造或交付。关于菲律宾的通知不清楚SII是否会向菲律宾运送疫苗，或者SII是否必须首先在菲律宾建造一个生产设施，从那里运送疫苗。声明中写道，“该疫苗将由SII以COVOVAX品牌在菲律宾生产和销售。”™为什么是“在菲律宾制造和销售”？是不是很笨拙？菲律宾于2021年3月宣布有意与SII合作在菲律宾进行制造。</blockquote></p><p>   “PH eyes&nbsp;local vaccine production&nbsp;with Serum Institute of India” March 17, 2021.  India has a general “restriction” on the export of COVID vaccines from India. It’s an unofficial “ban” on exports which are only allowed with government of India approval. It is also disconcerting that the application for approval of the Novavax vaccine has been&nbsp;submitted to India&nbsp;already on 5 August 2021 and it has not yet been approved by India.</p><p><blockquote>“PH关注印度血清研究所的本地疫苗生产”2021年3月17日。印度对从印度出口COVID疫苗有普遍的“限制”。这是一项非官方的出口“禁令”，只有在印度政府批准的情况下才允许。同样令人不安的是，Novavax疫苗的批准申请已于2021年8月5日提交给印度，但尚未获得印度的批准。</blockquote></p><p>   “He, however, clarified there was no ban on vaccine exports as neither the health ministry, commerce and industry ministry, department of promotion of industry and internal trade, nor the directorate general of foreign trade has issued any formal orders asking to bar the export of COVID-19 vaccines from the country.”COVID vaccines’ export&nbsp;may not resume before 2022.  Digging in news reports on deliveries to Indonesia indicate delivery of 20mil doses by the end of Dec 2021.Reuters&nbsp;reported on 18 November that, “India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source”.Shipment&nbsp;is likely to happen towards the end of next month, one of the sources said. Further reporting has SII potentially producing&nbsp;up to 100mil&nbsp;doses by the end of Dec 2021.</p><p><blockquote>“然而，他澄清说，没有禁止疫苗出口，因为卫生部、商业和工业部、工业和国内贸易部以及外贸总局都没有发布任何正式命令，要求禁止从该国出口新冠肺炎疫苗。”COVID疫苗的出口可能不会在2022年之前恢复。挖掘关于向印度尼西亚交付的新闻报道表明，到2021年12月底，将交付2000万剂疫苗。路透社11月18日报道称，“印度允许向印度尼西亚出口2000万剂Novavax疫苗——文件，来源”。其中一位消息人士称，发货可能会在下月底进行。进一步报告称，到2021年12月底，SII可能会生产多达1亿剂疫苗。</blockquote></p><p> The very bullish investment thesis for Novavax is still intact but investors cannot be expected to have tunnel vision on SII. Investors need quality communication from Novavax to maintain that investment thesis. The vacuum of information on the big picture for manufacturing, stockpiles, shipments, revenue, and income encourages wild speculation and rumor mongering.</p><p><blockquote>Novavax非常乐观的投资论点仍然完好无损，但不能指望投资者对SII有狭隘的看法。投资者需要Novavax的高质量沟通来维持这一投资论点。关于制造、库存、运输、收入和收入的信息真空鼓励了疯狂的猜测和谣言传播。</blockquote></p><p> <b>Burning Questions around Manufacturing, Stockpile and Shipments.</b></p><p><blockquote><b>围绕制造、库存和运输的紧迫问题。</b></blockquote></p><p></p><p> No amount of digging could provide substantiated answers to the following questions which are vital for investors to make informed decisions on investing in Novavax shares. Investors are forced to infer or speculate on the answers to many of these questions in the absence of facts. Perhaps some of these questions will be answered in the Fireside Chat with Evercore. Perhaps Novavax will become more forthcoming about its activities, but investors are desperate for reliable information. Most companies go out of their way to sit down with analysts and give them quality information empowering them to achieve the same outcomes as the guidance of the company. Novavax has been skirting the questions around manufacturing, stockpiles and shipments and it has become pressing for investors to have reliable information.</p><p><blockquote>再多的挖掘也无法为以下问题提供确凿的答案，这些问题对于投资者在投资Novavax股票时做出明智的决策至关重要。在缺乏事实的情况下，投资者被迫推断或推测其中许多问题的答案。也许其中一些问题会在与Evercore的炉边谈话中得到解答。也许Novavax会更加公开其活动，但投资者迫切需要可靠的信息。大多数公司都会特意与分析师坐下来，向他们提供高质量的信息，使他们能够实现与公司指导相同的结果。Novavax一直回避有关制造、库存和运输的问题，投资者迫切需要获得可靠的信息。</blockquote></p><p> The questions which follows can't be answered from available information. Investors are at risk in the absence of the information which should be readily available to be packaged for investors. Each question will be followed by an explanation why the information is important.</p><p><blockquote>接下来的问题无法从现有信息中回答。由于缺乏本应随时为投资者打包的信息，投资者面临风险。每个问题之后都会解释为什么这些信息很重要。</blockquote></p><p> <b>Manufacturing Questions</b></p><p><blockquote><b>制造问题</b></blockquote></p><p></p><p> <ol>  <li>Why has no other manufacturing facility, particularly the Novavax specific facilities, been submitted yet? Importance: Novavax was following a holistic approach towards achieving regulatory approval for all its manufacturing facilities up to the point when the&nbsp;Politico article&nbsp;was published on 19 October 2021. \"...we’ve built a&nbsp;global&nbsp;manufacturing infrastructure over the last year that has a robust eight different antigen manufacturing facilities in seven different countries.\" On 27 October 2021 Novavax filed for authorization of its vaccine in the UK and that filing was narrowed from a \"global manufacturing infrastructure\" to a single manufacturer filing that \"leverages our manufacturing partnership with the&nbsp;Serum Institute of India.In the near future, we expect to supplement this filing with supply from our global supply chain.\" All subsequent regulatory filings since 27 October 2021, other than South Korea were done in the same manner, leveraging SII as manufacturer.</li>  <li>Will all facilities now manufacture components and export them to SII for manufacturing or fill &amp; finish? Importance: Stanley Erck, CEO of Novavax said at the&nbsp;EC: \"And so they (SII) have fill finish capacity that's virtually unlimited. We can make many hundreds of millions of doses per month in their facility. And we've also signed an agreement with them, if we want for them to make product for high income markets. And so we have a CDMO agreement with them. And so they wouldn't supply as finished product, whether in one of two ways either from antigen, these spike protein that they make at Serum, or from spike protein that we make in our various sites around the world.\" The shift to SII seems to also imply greater reliance on the manufacturing capabilities of SII. It is important for investors to understand the implications of this shift.</li>  <li>Can SII export any vaccine doses without approvals from the Indian government? Importance: As indicated above, exports of COVID vaccines from India are presently subject to, at the very least, Indian government approvals. The shift towards utilizing SII manufacturing facilities requires understanding of the potential risk associated with reliance on a single manufacturer and single country.</li>  <li>SII reported communication on manufacturing is materially more conservative than Novavax reports, indicating only up to 100mil doses manufactured by the end of Dec 2021. Why the difference? Importance: John Trizzino said at the&nbsp;EC: \"Looking to the months ahead, we expect to achieve a manufacturing capacity of 150 million doses per month by the end of the fourth quarter.\" SII as quoted above expect to produce up to 100mil doses by the end of Dec 2021. The discrepancy between Novavax and SII is, between 150mil doses per month vs up to 100mil doses by the end of Dec 2021.</li>  <li>How much actual manufacturing of regulatory compliant vaccine doses are taking place at Novavax manufacturing facilities and all partner facilities? Not capacity, actual manufacturing. Importance: Novavax describes manufacturing as \"manufacturing capacity\" (see 4 above). SII indicated production of up to 100mil doses by the end of Dec 2021 and presently is the only manufacturer put forward in regulatory filings. Investors need information on the activities of the other manufacturers in the global manufacturing network to support the investment thesis particularly looking at 2022 and beyond. How and when would they start contributing to actual doses being available for deliveries?</li>  <li>When will all other manufacturing facilities be submitted for regulatory approvals? Importance: All other manufacturing facilities were supposed to have been included in the \"near future\" which is ambiguous. It's one month later and no guidance or filings have been made for any of these facilities.</li>  <li>What is the manufacturing guidance from all facilities say by Q1, Q2, Q3 and full year? Not capacity guidance, actual manufactured doses, regulatory compliant and available for shipment and delivery. Importance: This question follows from 6 above and the guidance is needed to estimate the revenue and income potential for Novavax during those periods. Novavax provided no guidance on full year 2021 or 2022 earnings during the EC.</li>  <li>Investors will need information on manufacturing at the different facilities to allow for reasoned estimates of sales into different regions as well as COVAX. What will be the composition of manufacturing and delivery for low value sales and for high value sales? Importance: Novavax's&nbsp;reported sales&nbsp;prices range from $3 per dose to $21. The allocations of manufactured doses from the various manufacturing facilities are important indicators of the potential revenue which can be expected from those deliveries. It is expected that a material portion of the&nbsp;SII manufacturing&nbsp;will initially go to COVAX and into markets where </p><p><blockquote><ol><li>为什么尚未提交其他生产设施，特别是Novavax特定设施？重要性：在Politico文章于2021年10月19日发表之前，Novavax一直在采取整体方法来获得监管机构的批准。“……去年我们建立了全球制造基础设施，在七个不同的国家拥有强大的八个不同的抗原制造设施。”2021年10月27日，Novavax在英国申请了其疫苗的授权，该申请从“全球制造基础设施”缩小到“利用我们与印度血清研究所的制造合作伙伴关系”的单一制造商申请。在不久的将来，我们预计将通过我们全球供应链的供应来补充该文件。”自2021年10月27日以来，除韩国外，所有后续监管备案均以相同方式完成，利用SII作为制造商。</li><li>所有工厂现在都会制造组件并将其出口到SII进行制造或灌装和精加工吗？重要性：Novavax首席执行官Stanley Erck在欧盟委员会上表示：“因此，他们（SII）拥有几乎无限的灌装能力。我们每个月可以在他们的工厂生产数亿剂。如果我们想让他们为高收入市场生产产品，我们也和他们签署了协议。所以我们和他们有CDMO协议。因此，他们不会作为成品供应，无论是通过两种方式之一，要么来自抗原（他们在血清中制造的刺突蛋白，要么来自我们在世界各地制造的刺突蛋白。”向SII的转变似乎也意味着对SII制造能力的更大依赖。对于投资者来说，理解这一转变的影响非常重要。</li><li>没有印度政府的批准，SII可以出口任何疫苗剂量吗？重要性：如上所述，从印度出口COVID疫苗目前至少需要印度政府的批准。转向利用SII制造设施需要了解与依赖单一制造商和单一国家相关的潜在风险。</li><li>SII报告的关于生产的沟通比Novavax的报告要保守得多，表明到2021年12月底仅生产了多达1亿剂。为什么会有区别？重要性：John Trizzino在EC表示：“展望未来几个月，我们预计到第四季度末将实现每月1.5亿剂的生产能力。”如上所述，SII预计到2021年12月底将生产多达1亿剂疫苗。Novavax和SII之间的差异是，到2021年12月底，每月1.5亿剂与高达1亿剂之间。</li><li>Novavax生产工厂和所有合作伙伴工厂实际生产了多少符合法规的疫苗剂量？不是产能，而是实际制造。重要性：Novavax将制造描述为“制造能力”（见上文4）。SII表示，到2021年12月底，产量将达到1亿剂，目前是唯一一家在监管文件中提出的制造商。投资者需要有关全球制造网络中其他制造商活动的信息，以支持投资论点，特别是着眼于2022年及以后的投资论点。他们将如何以及何时开始为可用于分娩的实际剂量做出贡献？</li><li>所有其他生产设施何时提交监管机构批准？重要性：所有其他制造设施都应该包括在“不久的将来”中，这是模糊的。一个月后，还没有对这些设施进行指导或备案。</li><li>第一季度、第二季度、第三季度和全年所有工厂的制造指导是什么？不是容量指南，实际生产剂量，符合法规，可用于装运和交付。重要性：这个问题来自上面的6个问题，需要指导来估计Novavax在这些时期的收入和收入潜力。Novavax在EC期间没有提供2021年或2022年全年收益指引。</li><li>投资者将需要有关不同工厂生产的信息，以便合理估计不同地区以及COVAX的销售额。低价值销售和高价值销售的制造和交付构成是什么？重要性：Novavax报告的销售价格从每剂3美元到21美元不等。来自各种制造设施的制造剂量的分配是可以从这些交付中预期的潜在收入的重要指标。预计SII制造的重要部分最初将流向COVAX和以下市场：</li></ol></blockquote></p><p></p><p> <ol>  <li>What is the size of the actual stockpile at SII, tens of millions can be 20mil doses or up to 90mil doses, it is far too inexact? Importance: The Novavax CEO answered at the EC: \"Well, I think I answered the second part of the question that SII will be the initial manufacturer. They've already made many 10s of millions of doses that are waiting to be shippable. They're sitting we've -- my team has physically gone over there and touched them.\" The stockpile can theoretically be shipped with immediate effect and generate income still in 2021. The actual size matters.</li>  <li>What is the size of the regulatory compliant stockpile of doses at all facilities combined, again, tens of millions are not exact enough? Importance: The communication at the EC was very fragmented but it seems that there may be inventory other than that at SII. Novavax CEO: \"And for each of these, we're trying to allocate product both that we have in inventory in the U.S. and Europe and South Korea and an inventory that's being built up at Serum...\" Better understanding of regulatory compliant available inventory at all facilities will inform investor expectations on the timing of revenue as well as the expected quantum thereof.</li>  <li>What is the breakdown of the stockpile at the various manufacturing facilities, those able to deliver a finished product? Importance: A breakdown of the stockpile will guide investor expectations regarding potential income from high value deliveries vs low value deliveries and the timing thereof.</li>  <li>There has been rumor that the 20mil dose export from SII was approved because of its expiry date, rumor is not where information should originate from. How dated is the various stockpiles?</li> </ol> <b>Shipment and Delivery Questions</b></p><p><blockquote><ol><li>SII的实际库存有多大，几千万可以是2000万剂，也可以是9000万剂，这太不准确了？重要性：Novavax首席执行官在EC上回答道：“嗯，我想我回答了问题的第二部分，即SII将是最初的制造商。他们已经生产了数千万剂疫苗，正在等待发货。他们坐在那里，我们——我的团队亲自去那里触摸了他们。”理论上，库存可以立即发货，并在2021年仍能产生收入。实际大小很重要。</li><li>所有设施的合规剂量库存加起来有多大，同样，数千万还不够准确？重要性：欧共体的沟通非常分散，但似乎可能有SII以外的库存。Novavax首席执行官：“对于每一种产品，我们都在尝试分配美国、欧洲和韩国库存的产品以及Serum正在建立的库存……”更好地了解所有设施中符合法规的可用库存将告知投资者对收入时间及其预期数量的预期。</li><li>能够交付成品的各种制造设施的库存细目是什么？重要性：库存的细分将指导投资者对高价值交付与低价值交付的潜在收入及其时间的预期。</li><li>有传言说，从SII出口的2000万剂疫苗因其有效期而被批准，谣言不是信息的来源。各种库存有多老？</li></ol><b>装运和交付问题</b></blockquote></p><p> <ol>  <li>Why will the 20mil shipment to Indonesia only take place by the end of Dec 2021 if the doses are available in stockpile right now? Importance: Novavax CEO at the EC: \"We've expect that initial shipments into Indonesia by Serum will begin imminently.\" The guidance of SII on delivery to Indonesia clearly differs from the comment by the CEO of Novavax. This question also has a larger context. How many doses can be expected to be shipped still in 2021 which will translate into revenue and income for the full year results EC in March 2022?</li>  <li>Why only 20mil doses? Importance: SII has tens of millions of doses in stockpile and can manufacture up to 100mil doses be the end of Dec 2021 yet only 20mil doses out of a 50mil doses order by Indonesia are expected to be shipped by end of Dec 2021.</li>  <li>How many doses are SII expected to ship in 2021? Importance: This question follows on q2 above. There are potential doses for shipment from stockpile and from manufacturing yet only 20mil has been reported.</li>  <li>Where will doses be shipped from in 2022, which manufacturing facilities? Importance: The shift in emphasis to SII for the time being raises this question. Which of the other manufacturing facilities in the global manufacturing network will be designated to ship finished product?</li>  <li>How many doses are expected be shipped and delivered in H1 and full year in 2022. Importance: All of the Novavax guidance is \"manufacturing capacity\" which informs investors what the maximum potential production capacity may be, but it does not inform the investor how much actual manufacturing can be expected within a given period, manufactured product which can be delivered under sales agreements.</li>  <li>Why are no shipments to the Philippines scheduled so far? Importance: A tiny shipment of 20mil doses has been reported for Indonesia but no scheduled delivery to the Philippines has been reported so far.</li> </ol> Filing for regulatory approvals in the name of SII as manufacturer surely advances the standing of the Novavax vaccine but it needs to be backed up by manufacturing and an ability to export the vaccines to those countries who had purchased doses. The presence of the Indian government looms large in the manufacturing and shipments of doses from SII. This vulnerability of Novavax to a single supplier/manufacturer must be explored and understood. Yes, the other facilities will in time also contribute, but guidance so far has been that those facilities should have been in play already and they are not. Investors need to understand, why not? When will those facilities contribute regulatory approved doses and contribute to the revenue and income of Novavax?</p><p><blockquote><ol><li>如果现在有库存，为什么2000万剂要到2021年12月底才能向印度尼西亚运送？重要性：Novavax首席执行官在欧盟表示：“我们预计血清将很快开始向印度尼西亚运送。”SII关于向印尼交货的指导与Novavax首席执行官的评论明显不同。这个问题还有一个更大的背景。预计2021年仍有多少剂量将转化为2022年3月全年业绩EC的收入和收入？</li><li>为什么只有2000万剂？重要性：SII有数千万剂库存，到2021年12月底可以生产多达1亿剂，但印度尼西亚订购的5000万剂中只有2000万剂预计到2021年12月底发货。</li><li>SII预计在2021年发货多少剂？重要性：这个问题在上面的q2之后。库存和生产中都有潜在的剂量可供运输，但据报道只有2000万。</li><li>2022年，剂量将从哪里运送，哪些制造设施？重要性：重点暂时转移到SII提出了这个问题。全球制造网络中的哪些其他制造工厂将被指定运送成品？</li><li>预计2022年H1和全年将运送和交付多少剂疫苗。重要性：Novavax的所有指导都是“制造能力”，它告诉投资者最大潜在生产能力是多少，但它没有告诉投资者在给定时期内可以预期多少实际制造，可以根据销售协议交付的制造产品。</li><li>为什么到目前为止还没有计划向菲律宾发货？重要性：据报道，有2000万剂疫苗运往印度尼西亚，但到目前为止，还没有计划运往菲律宾的报道。</li></ol>以SII作为制造商的名义申请监管部门的批准肯定会提高Novavax疫苗的地位，但它需要得到制造和向购买疫苗的国家出口疫苗的能力的支持。在从SII制造和运输剂量方面，印度政府的存在举足轻重。必须探索和理解Novavax对单一供应商/制造商的这种脆弱性。是的，其他设施也将及时做出贡献，但迄今为止的指导是，这些设施应该已经投入使用，但它们没有。投资者需要理解，何乐而不为呢？这些设施何时会贡献监管批准的剂量并为Novavax的收入和收益做出贡献？</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p></p><p> Novavax has made good progress since the&nbsp;Politico&nbsp;article to prove its ability to manufacture and deliver vaccine doses. Concentrating all the filings and all the manufacturing at SII are exposing Novavax to a single source manufacturer/supplier and political risk. The absence of information on manufacturing, stockpiles and shipments have become burning questions for investors. 2021 is almost over and only one shipment for 20mil vaccine doses is scheduled for the end of Dec 2021. It is hoped that Novavax will initiate a process to provide quality information on the burning questions around manufacturing, stockpiles and shipments and perhaps deal with some of it at the Evercore Fireside Chat. Investors require quality information to inform their decisions to buy Novavax shares and hold them based upon an informed investment thesis. The information currently available is lacking in that regard given a significant strategic shift by Novavax since the publication of the Politico article.</p><p><blockquote>自Politico发表文章以来，Novavax取得了良好进展，证明了其生产和提供疫苗剂量的能力。将所有备案和所有生产集中在SII使Novavax面临单一来源制造商/供应商和政治风险。缺乏有关制造、库存和出货量的信息已成为投资者面临的紧迫问题。2021年即将结束，只有一批2000万剂疫苗计划在2021年12月底发货。希望Novavax能够启动一个流程，提供有关制造、库存和运输等紧迫问题的高质量信息，并可能在Evercore炉边谈话中解决其中一些问题。投资者需要高质量的信息来决定购买Novavax股票并根据明智的投资论点持有这些股票。鉴于自Politico文章发表以来Novavax发生了重大战略转变，目前缺乏这方面的信息。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4471943-novavax-nvax-stock-some-burning-questions\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/article/4471943-novavax-nvax-stock-some-burning-questions","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172101126","content_text":"Summary\n\nNovavax is making good progress with SII backed regulatory filings.\nSII and the Indian government “ban” on COVID vaccine exports are a necessary vulnerability in the short term.\nInvestors cannot have tunnel vision on SII and Novavax must urgently provide answers on manufacturing, stockpiles, and shipments.\n\nMaria Golenishcheva/iStock via Getty Images\nNovavax(NASDAQ:NVAX)has announced its intention to participate in a Fireside Chat at Evercore ISI's 4th Annual HealthCONx Virtual Conference on 2 December 2021. This is the first event at which Novavax will participate since the Earnings Call(EC)on 4 November 2021.BioNTech(NASDAQ:BNTX) has participated in 3 events since their EC on 9 Nov including the Jefferies London Healthcare Conference and will also participate in the Evercore event.Moderna(NASDAQ:MRNA) also has participated in 3 events since their EC on 4 Nov and have announced participation in two more before 2 Dec but has not yet advised if they will be attending Evercore. Participating at events provide investors with general information. Novavax's absence form events in November has left a lot of questions unanswered.\nNovavax has announced the following successes since the EC:\n\nSubmission of Biologics License Application in South Korea for Approval of NVX-CoV2373.\nNovavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines.\nNovavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization.\nNovavax Files for Interim Authorization of COVID-19 Vaccine in Singapore.\n\nThe Novavax progress continues but at the same time the vacuum of information on manufacturing and delivery remains. It is important to discuss the burning questions and the lack of information on manufacturing, stockpile, and delivery.\nNone of the recent notices made specific reference to manufacturing or delivery. The notice on the Philippines is not clear on whether SII will be delivering vaccine doses to the Philippines at all or whether SII must first construct a manufacturing facility in the Philippines from which vaccines will be delivered. The statement reads, “The vaccine will be manufactured and marketed in the Philippines by SII under the brand name COVOVAX™.” Why this wording “manufactured and marketed in the Philippines”? Was it just clumsy or not? The Philippines announced an intention in March 2021 to partner with SII for manufacturing in the Philippines.\n\n “PH eyes local vaccine production with Serum Institute of India” March 17, 2021.\n\nIndia has a general “restriction” on the export of COVID vaccines from India. It’s an unofficial “ban” on exports which are only allowed with government of India approval. It is also disconcerting that the application for approval of the Novavax vaccine has been submitted to India already on 5 August 2021 and it has not yet been approved by India.\n\n “He, however, clarified there was no ban on vaccine exports as neither the health ministry, commerce and industry ministry, department of promotion of industry and internal trade, nor the directorate general of foreign trade has issued any formal orders asking to bar the export of COVID-19 vaccines from the country.”COVID vaccines’ export may not resume before 2022.\n\nDigging in news reports on deliveries to Indonesia indicate delivery of 20mil doses by the end of Dec 2021.Reuters reported on 18 November that, “India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source”.Shipment is likely to happen towards the end of next month, one of the sources said. Further reporting has SII potentially producing up to 100mil doses by the end of Dec 2021.\nThe very bullish investment thesis for Novavax is still intact but investors cannot be expected to have tunnel vision on SII. Investors need quality communication from Novavax to maintain that investment thesis. The vacuum of information on the big picture for manufacturing, stockpiles, shipments, revenue, and income encourages wild speculation and rumor mongering.\nBurning Questions around Manufacturing, Stockpile and Shipments.\nNo amount of digging could provide substantiated answers to the following questions which are vital for investors to make informed decisions on investing in Novavax shares. Investors are forced to infer or speculate on the answers to many of these questions in the absence of facts. Perhaps some of these questions will be answered in the Fireside Chat with Evercore. Perhaps Novavax will become more forthcoming about its activities, but investors are desperate for reliable information. Most companies go out of their way to sit down with analysts and give them quality information empowering them to achieve the same outcomes as the guidance of the company. Novavax has been skirting the questions around manufacturing, stockpiles and shipments and it has become pressing for investors to have reliable information.\nThe questions which follows can't be answered from available information. Investors are at risk in the absence of the information which should be readily available to be packaged for investors. Each question will be followed by an explanation why the information is important.\nManufacturing Questions\n\nWhy has no other manufacturing facility, particularly the Novavax specific facilities, been submitted yet? Importance: Novavax was following a holistic approach towards achieving regulatory approval for all its manufacturing facilities up to the point when the Politico article was published on 19 October 2021. \"...we’ve built a global manufacturing infrastructure over the last year that has a robust eight different antigen manufacturing facilities in seven different countries.\" On 27 October 2021 Novavax filed for authorization of its vaccine in the UK and that filing was narrowed from a \"global manufacturing infrastructure\" to a single manufacturer filing that \"leverages our manufacturing partnership with the Serum Institute of India.In the near future, we expect to supplement this filing with supply from our global supply chain.\" All subsequent regulatory filings since 27 October 2021, other than South Korea were done in the same manner, leveraging SII as manufacturer.\nWill all facilities now manufacture components and export them to SII for manufacturing or fill & finish? Importance: Stanley Erck, CEO of Novavax said at the EC: \"And so they (SII) have fill finish capacity that's virtually unlimited. We can make many hundreds of millions of doses per month in their facility. And we've also signed an agreement with them, if we want for them to make product for high income markets. And so we have a CDMO agreement with them. And so they wouldn't supply as finished product, whether in one of two ways either from antigen, these spike protein that they make at Serum, or from spike protein that we make in our various sites around the world.\" The shift to SII seems to also imply greater reliance on the manufacturing capabilities of SII. It is important for investors to understand the implications of this shift.\nCan SII export any vaccine doses without approvals from the Indian government? Importance: As indicated above, exports of COVID vaccines from India are presently subject to, at the very least, Indian government approvals. The shift towards utilizing SII manufacturing facilities requires understanding of the potential risk associated with reliance on a single manufacturer and single country.\nSII reported communication on manufacturing is materially more conservative than Novavax reports, indicating only up to 100mil doses manufactured by the end of Dec 2021. Why the difference? Importance: John Trizzino said at the EC: \"Looking to the months ahead, we expect to achieve a manufacturing capacity of 150 million doses per month by the end of the fourth quarter.\" SII as quoted above expect to produce up to 100mil doses by the end of Dec 2021. The discrepancy between Novavax and SII is, between 150mil doses per month vs up to 100mil doses by the end of Dec 2021.\nHow much actual manufacturing of regulatory compliant vaccine doses are taking place at Novavax manufacturing facilities and all partner facilities? Not capacity, actual manufacturing. Importance: Novavax describes manufacturing as \"manufacturing capacity\" (see 4 above). SII indicated production of up to 100mil doses by the end of Dec 2021 and presently is the only manufacturer put forward in regulatory filings. Investors need information on the activities of the other manufacturers in the global manufacturing network to support the investment thesis particularly looking at 2022 and beyond. How and when would they start contributing to actual doses being available for deliveries?\nWhen will all other manufacturing facilities be submitted for regulatory approvals? Importance: All other manufacturing facilities were supposed to have been included in the \"near future\" which is ambiguous. It's one month later and no guidance or filings have been made for any of these facilities.\nWhat is the manufacturing guidance from all facilities say by Q1, Q2, Q3 and full year? Not capacity guidance, actual manufactured doses, regulatory compliant and available for shipment and delivery. Importance: This question follows from 6 above and the guidance is needed to estimate the revenue and income potential for Novavax during those periods. Novavax provided no guidance on full year 2021 or 2022 earnings during the EC.\nInvestors will need information on manufacturing at the different facilities to allow for reasoned estimates of sales into different regions as well as COVAX. What will be the composition of manufacturing and delivery for low value sales and for high value sales? Importance: Novavax's reported sales prices range from $3 per dose to $21. The allocations of manufactured doses from the various manufacturing facilities are important indicators of the potential revenue which can be expected from those deliveries. It is expected that a material portion of the SII manufacturing will initially go to COVAX and into markets where the sales price would be towards the lower bound while the manufacturing at the other facilities in the EU, UK and USA may generate higher revenues. Novavax CEO at the EC: \"Serum is going to make the bulk of the production over the next few months. We are going to allocate. We're going to focus on COVAX, and make sure that they get their allocation, it won't be 100% of our product out of there. But it will be a large portion for the first few months. And then it'll shift over to our APAs in large quantities, I think in the second, third quarter. So this quarter and next quarter, we have a lot of our mission is to get a lot of product out to low and middle income countries...\" Better understanding of the revenue potential is required. Does this statement mean that Novavax will only start generating significant income from Q3 onwards? Will the EC's between now and November 2022 be relatively thin on revenue and income? The language of \"near future\" on facilities other than SII is in conflict with the language of SII manufacturing the bulk over the \"next few months\".\n\nStockpile Questions\n\nWhat is the size of the actual stockpile at SII, tens of millions can be 20mil doses or up to 90mil doses, it is far too inexact? Importance: The Novavax CEO answered at the EC: \"Well, I think I answered the second part of the question that SII will be the initial manufacturer. They've already made many 10s of millions of doses that are waiting to be shippable. They're sitting we've -- my team has physically gone over there and touched them.\" The stockpile can theoretically be shipped with immediate effect and generate income still in 2021. The actual size matters.\nWhat is the size of the regulatory compliant stockpile of doses at all facilities combined, again, tens of millions are not exact enough? Importance: The communication at the EC was very fragmented but it seems that there may be inventory other than that at SII. Novavax CEO: \"And for each of these, we're trying to allocate product both that we have in inventory in the U.S. and Europe and South Korea and an inventory that's being built up at Serum...\" Better understanding of regulatory compliant available inventory at all facilities will inform investor expectations on the timing of revenue as well as the expected quantum thereof.\nWhat is the breakdown of the stockpile at the various manufacturing facilities, those able to deliver a finished product? Importance: A breakdown of the stockpile will guide investor expectations regarding potential income from high value deliveries vs low value deliveries and the timing thereof.\nThere has been rumor that the 20mil dose export from SII was approved because of its expiry date, rumor is not where information should originate from. How dated is the various stockpiles?\n\nShipment and Delivery Questions\n\nWhy will the 20mil shipment to Indonesia only take place by the end of Dec 2021 if the doses are available in stockpile right now? Importance: Novavax CEO at the EC: \"We've expect that initial shipments into Indonesia by Serum will begin imminently.\" The guidance of SII on delivery to Indonesia clearly differs from the comment by the CEO of Novavax. This question also has a larger context. How many doses can be expected to be shipped still in 2021 which will translate into revenue and income for the full year results EC in March 2022?\nWhy only 20mil doses? Importance: SII has tens of millions of doses in stockpile and can manufacture up to 100mil doses be the end of Dec 2021 yet only 20mil doses out of a 50mil doses order by Indonesia are expected to be shipped by end of Dec 2021.\nHow many doses are SII expected to ship in 2021? Importance: This question follows on q2 above. There are potential doses for shipment from stockpile and from manufacturing yet only 20mil has been reported.\nWhere will doses be shipped from in 2022, which manufacturing facilities? Importance: The shift in emphasis to SII for the time being raises this question. Which of the other manufacturing facilities in the global manufacturing network will be designated to ship finished product?\nHow many doses are expected be shipped and delivered in H1 and full year in 2022. Importance: All of the Novavax guidance is \"manufacturing capacity\" which informs investors what the maximum potential production capacity may be, but it does not inform the investor how much actual manufacturing can be expected within a given period, manufactured product which can be delivered under sales agreements.\nWhy are no shipments to the Philippines scheduled so far? Importance: A tiny shipment of 20mil doses has been reported for Indonesia but no scheduled delivery to the Philippines has been reported so far.\n\nFiling for regulatory approvals in the name of SII as manufacturer surely advances the standing of the Novavax vaccine but it needs to be backed up by manufacturing and an ability to export the vaccines to those countries who had purchased doses. The presence of the Indian government looms large in the manufacturing and shipments of doses from SII. This vulnerability of Novavax to a single supplier/manufacturer must be explored and understood. Yes, the other facilities will in time also contribute, but guidance so far has been that those facilities should have been in play already and they are not. Investors need to understand, why not? When will those facilities contribute regulatory approved doses and contribute to the revenue and income of Novavax?\nConclusion\nNovavax has made good progress since the Politico article to prove its ability to manufacture and deliver vaccine doses. Concentrating all the filings and all the manufacturing at SII are exposing Novavax to a single source manufacturer/supplier and political risk. The absence of information on manufacturing, stockpiles and shipments have become burning questions for investors. 2021 is almost over and only one shipment for 20mil vaccine doses is scheduled for the end of Dec 2021. It is hoped that Novavax will initiate a process to provide quality information on the burning questions around manufacturing, stockpiles and shipments and perhaps deal with some of it at the Evercore Fireside Chat. Investors require quality information to inform their decisions to buy Novavax shares and hold them based upon an informed investment thesis. The information currently available is lacking in that regard given a significant strategic shift by Novavax since the publication of the Politico article.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858986168,"gmtCreate":1634963204435,"gmtModify":1634963204623,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Oops","listText":"Oops","text":"Oops","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/858986168","repostId":"1172683205","repostType":4,"isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609466872,"gmtCreate":1638318364992,"gmtModify":1638318364992,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Virus again....","listText":"Virus again....","text":"Virus again....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609466872","repostId":"2188758534","repostType":4,"isVote":1,"tweetType":1,"viewCount":1047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874079360,"gmtCreate":1637715936283,"gmtModify":1637715936347,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/874079360","repostId":"2185336565","repostType":4,"isVote":1,"tweetType":1,"viewCount":674,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849925648,"gmtCreate":1635725695604,"gmtModify":1635725695604,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Hmm....","listText":"Hmm....","text":"Hmm....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/849925648","repostId":"1150912013","repostType":4,"repost":{"id":"1150912013","kind":"news","pubTimestamp":1635724788,"share":"https://www.laohu8.com/m/news/1150912013?lang=zh_CN&edition=full","pubTime":"2021-11-01 07:59","market":"us","language":"en","title":"What's the best month for stocks? Hint: the next four weeks<blockquote>股票最好的月份是哪个月？提示：接下来的四周</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1150912013","media":"finance.yahoo","summary":"The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.The start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.Historically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.“November is t","content":"<p>The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.</p><p><blockquote>如果历史有任何迹象的话，股市创纪录的走势将在未来几周内获得动力。</blockquote></p><p> The start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.</p><p><blockquote>假期的开始通常是华尔街一年中的强劲时期，分析师指出，这种模式是保持乐观的理由，即股市在经历了动荡的9月份后将保持在历史高点。</blockquote></p><p> Historically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.</p><p><blockquote>根据LPL Financial的数据，从历史上看，11月一直是股市一年中表现最好的月份——无论是自1950年以来还是过去十年。</blockquote></p><p> That’s not all. History shows the stock market’s strongest six-month period is November to April, according to the Stock Trader’s Almanac. November is also the first month of the market’s best three-month stretch, November to January.</p><p><blockquote>这还不是全部。根据股票交易者年鉴，历史表明股市最强劲的六个月是11月至4月。11月也是市场最好的三个月（11月至1月）的第一个月。</blockquote></p><p> Why is November the best?</p><p><blockquote>为什么11月是最好的？</blockquote></p><p> This seasonal strength is created by a combination of factors. For one thing, the final three months of the year are typically the best for stocks, with stocks rising 3.8% on average, according to LPL Financial.</p><p><blockquote>这种季节性强势是由多种因素共同造成的。一方面，根据LPL Financial的数据，一年中的最后三个月通常是股市最好的月份，股市平均上涨3.8%。</blockquote></p><p> Strong spending by shoppers during the holidays also tends to translate into strong quarters for consumer-focused businesses. Some analysts also attribute it to optimism during the holiday season, year-end portfolio adjustments and investors being on vacation.</p><p><blockquote>购物者在假期期间的强劲支出也往往会转化为以消费者为中心的企业的强劲季度。一些分析师还将其归因于假期期间的乐观情绪、年终投资组合调整以及投资者正在度假。</blockquote></p><p> “November is the best month of the year, but it doesn’t seem to get nearly as much love as you’d think,” Ryan Detrick, chief market strategist at LPL Financial, said in a note to clients. “We all assume December is the best month, but November is actually better and gets very little fanfare. Maybe it should be a month for the bulls, not for turkeys.”</p><p><blockquote>LPL Financial首席市场策略师瑞安·德特里克(Ryan Detrick)在给客户的一份报告中表示：“11月是一年中最好的月份，但它似乎并没有你想象的那么受欢迎。”“我们都认为12月是最好的月份，但11月实际上更好，而且很少大张旗鼓。也许这应该是多头的月份，而不是火鸡的月份。”</blockquote></p><p> Wall Street avoids spooky October</p><p><blockquote>华尔街避免幽灵般的十月</blockquote></p><p> While October is often considered a spooky month for investors, earning a bad reputation following the crashes of 1929, 1987 and during the global financial crisis in 2008, investors weren’t so fearful this year.</p><p><blockquote>虽然10月份对投资者来说通常被认为是一个幽灵般的月份，在1929年、1987年的崩盘和2008年全球金融危机期间赢得了坏名声，但今年投资者并没有那么害怕。</blockquote></p><p> After the S&amp;P 500 recorded its biggest monthly loss since the start of the coronavirus pandemic in September, the broad index rebounded more than 6% in October on further signs that corporate profits are growing once again following last year's recession.</p><p><blockquote>在标普500 9月份录得自冠状病毒大流行开始以来的最大月度跌幅后，由于有进一步迹象表明企业利润在去年衰退后再次增长，该指数在10月份反弹了6%以上。</blockquote></p><p> “It looks as though the market has resisted ‘Octoberphobia’ and averted the feared crashes or massacres that have given the month its bad reputation,” Jeff Hirsch, editor of the Stock Trader's Almanac, said in a note to clients.</p><p><blockquote>《股票交易者年鉴》编辑杰夫·赫希(Jeff Hirsch)在给客户的一份报告中表示：“看起来市场已经抵制了‘十月恐惧症’，避免了令人恐惧的崩盘或大屠杀，这些崩盘或大屠杀给这个月带来了坏名声。”</blockquote></p><p> To be sure, November has taken hits during bear markets, when major averages drop more than 20% from a recent peak.</p><p><blockquote>可以肯定的是，11月份在熊市期间遭受了打击，主要股指较近期峰值下跌了20%以上。</blockquote></p><p> For instance, November 2000 was the Nasdaq Composite’s second-worst month on record, with the technology-focused index plunging nearly 23%, according to the Stock Trader’s Almanac. Only October 1987 was worse, and that is when the \"Black Monday\" stock market crash occurred</p><p><blockquote>例如，根据股票交易者年鉴，2000年11月是纳斯达克综合指数有记录以来第二糟糕的月份，以科技为重点的指数暴跌近23%。只有1987年10月更糟糕，那是“黑色星期一”股灾发生的时候</blockquote></p><p> Why investors should be optimistic</p><p><blockquote>为什么投资者应该乐观</blockquote></p><p> The U.S. economy&nbsp;slowed substantially from July through September&nbsp;following a series of obstacles, including a surge in COVID-19 cases, supply chain bottlenecks, rising consumer prices and the fading effects of federal stimulus measures.</p><p><blockquote>在经历了一系列障碍后，美国经济从7月到9月大幅放缓，包括COVID-19病例激增、供应链瓶颈、消费者价格上涨以及联邦刺激措施效果减弱。</blockquote></p><p> But with COVID-19 cases now falling and vaccinations rising, most economists are branding the weak showing a soft patch in a still-robust recovery from the pandemic-induced recession, with a healthy rebound projected in the final months of the year.</p><p><blockquote>但随着新冠肺炎病例的下降和疫苗接种的增加，大多数经济学家认为，在从大流行引发的衰退中仍然强劲的复苏中，疲软表现出疲软，预计今年最后几个月将出现健康反弹。</blockquote></p><p> There are signs that there could be more gains to come on Wall Street in the final months of the year on strong seasonality trends, better-than-expected corporate earnings and falling COVID-19 cases. Market breadth has also improved, meaning that more stocks are participating in the rally, a sign of a healthy and strong market.</p><p><blockquote>有迹象表明，由于强劲的季节性趋势、好于预期的企业盈利以及COVID-19病例下降，今年最后几个月华尔街可能会出现更多上涨。市场广度也有所改善，这意味着更多股票参与涨势，这是市场健康强劲的标志。</blockquote></p><p> Jobless claims have also fallen steadily in recent weeks, with continuing claims sliding below 2.5 million recently for the first time since the coronavirus pandemic began.</p><p><blockquote>最近几周，申请失业救济人数也在稳步下降，最近申请失业救济人数自冠状病毒大流行开始以来首次降至250万以下。</blockquote></p><p> After suffering its first 5% pullback of 2021 in early October, the S&amp;P 500 has come roaring back and closed at a record high on October 21. The S&amp;P 500 Index has gained more than 20% so far this year, making more than 50 record highs along the way.</p><p><blockquote>在10月初经历了2021年首次5%的回调后，标普500卷土重来，并于10月21日收于历史新高。标普500指数今年迄今已上涨超过20%，一路上创下50多个历史新高。</blockquote></p><p> That could be a positive sign for investors in the coming months. The past seven times the S&amp;P 500 had risen 15% for the year heading into the fourth quarter, that final quarter ended up higher each time, rising 5.8%, data from LPL Financial showed.</p><p><blockquote>这对未来几个月的投资者来说可能是一个积极的信号。LPL Financial的数据显示，过去七次标普500在第四季度之前上涨了15%，最后一个季度每次都上涨了5.8%。</blockquote></p><p> “We firmly believe that new highs are something to be embraced, not feared, and history shows that new highs tend to come in bunches—something that has certainly been true so far this year,” according to Detrick.</p><p><blockquote>德特里克表示：“我们坚信，新高是值得拥抱的，而不是害怕的，历史表明，新高往往会成群结队地出现——今年到目前为止，情况确实如此。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the best month for stocks? Hint: the next four weeks<blockquote>股票最好的月份是哪个月？提示：接下来的四周</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the best month for stocks? Hint: the next four weeks<blockquote>股票最好的月份是哪个月？提示：接下来的四周</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-11-01 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.</p><p><blockquote>如果历史有任何迹象的话，股市创纪录的走势将在未来几周内获得动力。</blockquote></p><p> The start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.</p><p><blockquote>假期的开始通常是华尔街一年中的强劲时期，分析师指出，这种模式是保持乐观的理由，即股市在经历了动荡的9月份后将保持在历史高点。</blockquote></p><p> Historically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.</p><p><blockquote>根据LPL Financial的数据，从历史上看，11月一直是股市一年中表现最好的月份——无论是自1950年以来还是过去十年。</blockquote></p><p> That’s not all. History shows the stock market’s strongest six-month period is November to April, according to the Stock Trader’s Almanac. November is also the first month of the market’s best three-month stretch, November to January.</p><p><blockquote>这还不是全部。根据股票交易者年鉴，历史表明股市最强劲的六个月是11月至4月。11月也是市场最好的三个月（11月至1月）的第一个月。</blockquote></p><p> Why is November the best?</p><p><blockquote>为什么11月是最好的？</blockquote></p><p> This seasonal strength is created by a combination of factors. For one thing, the final three months of the year are typically the best for stocks, with stocks rising 3.8% on average, according to LPL Financial.</p><p><blockquote>这种季节性强势是由多种因素共同造成的。一方面，根据LPL Financial的数据，一年中的最后三个月通常是股市最好的月份，股市平均上涨3.8%。</blockquote></p><p> Strong spending by shoppers during the holidays also tends to translate into strong quarters for consumer-focused businesses. Some analysts also attribute it to optimism during the holiday season, year-end portfolio adjustments and investors being on vacation.</p><p><blockquote>购物者在假期期间的强劲支出也往往会转化为以消费者为中心的企业的强劲季度。一些分析师还将其归因于假期期间的乐观情绪、年终投资组合调整以及投资者正在度假。</blockquote></p><p> “November is the best month of the year, but it doesn’t seem to get nearly as much love as you’d think,” Ryan Detrick, chief market strategist at LPL Financial, said in a note to clients. “We all assume December is the best month, but November is actually better and gets very little fanfare. Maybe it should be a month for the bulls, not for turkeys.”</p><p><blockquote>LPL Financial首席市场策略师瑞安·德特里克(Ryan Detrick)在给客户的一份报告中表示：“11月是一年中最好的月份，但它似乎并没有你想象的那么受欢迎。”“我们都认为12月是最好的月份，但11月实际上更好，而且很少大张旗鼓。也许这应该是多头的月份，而不是火鸡的月份。”</blockquote></p><p> Wall Street avoids spooky October</p><p><blockquote>华尔街避免幽灵般的十月</blockquote></p><p> While October is often considered a spooky month for investors, earning a bad reputation following the crashes of 1929, 1987 and during the global financial crisis in 2008, investors weren’t so fearful this year.</p><p><blockquote>虽然10月份对投资者来说通常被认为是一个幽灵般的月份，在1929年、1987年的崩盘和2008年全球金融危机期间赢得了坏名声，但今年投资者并没有那么害怕。</blockquote></p><p> After the S&amp;P 500 recorded its biggest monthly loss since the start of the coronavirus pandemic in September, the broad index rebounded more than 6% in October on further signs that corporate profits are growing once again following last year's recession.</p><p><blockquote>在标普500 9月份录得自冠状病毒大流行开始以来的最大月度跌幅后，由于有进一步迹象表明企业利润在去年衰退后再次增长，该指数在10月份反弹了6%以上。</blockquote></p><p> “It looks as though the market has resisted ‘Octoberphobia’ and averted the feared crashes or massacres that have given the month its bad reputation,” Jeff Hirsch, editor of the Stock Trader's Almanac, said in a note to clients.</p><p><blockquote>《股票交易者年鉴》编辑杰夫·赫希(Jeff Hirsch)在给客户的一份报告中表示：“看起来市场已经抵制了‘十月恐惧症’，避免了令人恐惧的崩盘或大屠杀，这些崩盘或大屠杀给这个月带来了坏名声。”</blockquote></p><p> To be sure, November has taken hits during bear markets, when major averages drop more than 20% from a recent peak.</p><p><blockquote>可以肯定的是，11月份在熊市期间遭受了打击，主要股指较近期峰值下跌了20%以上。</blockquote></p><p> For instance, November 2000 was the Nasdaq Composite’s second-worst month on record, with the technology-focused index plunging nearly 23%, according to the Stock Trader’s Almanac. Only October 1987 was worse, and that is when the \"Black Monday\" stock market crash occurred</p><p><blockquote>例如，根据股票交易者年鉴，2000年11月是纳斯达克综合指数有记录以来第二糟糕的月份，以科技为重点的指数暴跌近23%。只有1987年10月更糟糕，那是“黑色星期一”股灾发生的时候</blockquote></p><p> Why investors should be optimistic</p><p><blockquote>为什么投资者应该乐观</blockquote></p><p> The U.S. economy&nbsp;slowed substantially from July through September&nbsp;following a series of obstacles, including a surge in COVID-19 cases, supply chain bottlenecks, rising consumer prices and the fading effects of federal stimulus measures.</p><p><blockquote>在经历了一系列障碍后，美国经济从7月到9月大幅放缓，包括COVID-19病例激增、供应链瓶颈、消费者价格上涨以及联邦刺激措施效果减弱。</blockquote></p><p> But with COVID-19 cases now falling and vaccinations rising, most economists are branding the weak showing a soft patch in a still-robust recovery from the pandemic-induced recession, with a healthy rebound projected in the final months of the year.</p><p><blockquote>但随着新冠肺炎病例的下降和疫苗接种的增加，大多数经济学家认为，在从大流行引发的衰退中仍然强劲的复苏中，疲软表现出疲软，预计今年最后几个月将出现健康反弹。</blockquote></p><p> There are signs that there could be more gains to come on Wall Street in the final months of the year on strong seasonality trends, better-than-expected corporate earnings and falling COVID-19 cases. Market breadth has also improved, meaning that more stocks are participating in the rally, a sign of a healthy and strong market.</p><p><blockquote>有迹象表明，由于强劲的季节性趋势、好于预期的企业盈利以及COVID-19病例下降，今年最后几个月华尔街可能会出现更多上涨。市场广度也有所改善，这意味着更多股票参与涨势，这是市场健康强劲的标志。</blockquote></p><p> Jobless claims have also fallen steadily in recent weeks, with continuing claims sliding below 2.5 million recently for the first time since the coronavirus pandemic began.</p><p><blockquote>最近几周，申请失业救济人数也在稳步下降，最近申请失业救济人数自冠状病毒大流行开始以来首次降至250万以下。</blockquote></p><p> After suffering its first 5% pullback of 2021 in early October, the S&amp;P 500 has come roaring back and closed at a record high on October 21. The S&amp;P 500 Index has gained more than 20% so far this year, making more than 50 record highs along the way.</p><p><blockquote>在10月初经历了2021年首次5%的回调后，标普500卷土重来，并于10月21日收于历史新高。标普500指数今年迄今已上涨超过20%，一路上创下50多个历史新高。</blockquote></p><p> That could be a positive sign for investors in the coming months. The past seven times the S&amp;P 500 had risen 15% for the year heading into the fourth quarter, that final quarter ended up higher each time, rising 5.8%, data from LPL Financial showed.</p><p><blockquote>这对未来几个月的投资者来说可能是一个积极的信号。LPL Financial的数据显示，过去七次标普500在第四季度之前上涨了15%，最后一个季度每次都上涨了5.8%。</blockquote></p><p> “We firmly believe that new highs are something to be embraced, not feared, and history shows that new highs tend to come in bunches—something that has certainly been true so far this year,” according to Detrick.</p><p><blockquote>德特里克表示：“我们坚信，新高是值得拥抱的，而不是害怕的，历史表明，新高往往会成群结队地出现——今年到目前为止，情况确实如此。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/whats-best-month-stocks-hint-110106336.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/whats-best-month-stocks-hint-110106336.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150912013","content_text":"The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.\nThe start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.\nHistorically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.\nThat’s not all. History shows the stock market’s strongest six-month period is November to April, according to the Stock Trader’s Almanac. November is also the first month of the market’s best three-month stretch, November to January.\nWhy is November the best?\nThis seasonal strength is created by a combination of factors. For one thing, the final three months of the year are typically the best for stocks, with stocks rising 3.8% on average, according to LPL Financial.\nStrong spending by shoppers during the holidays also tends to translate into strong quarters for consumer-focused businesses. Some analysts also attribute it to optimism during the holiday season, year-end portfolio adjustments and investors being on vacation.\n“November is the best month of the year, but it doesn’t seem to get nearly as much love as you’d think,” Ryan Detrick, chief market strategist at LPL Financial, said in a note to clients. “We all assume December is the best month, but November is actually better and gets very little fanfare. Maybe it should be a month for the bulls, not for turkeys.”\nWall Street avoids spooky October\nWhile October is often considered a spooky month for investors, earning a bad reputation following the crashes of 1929, 1987 and during the global financial crisis in 2008, investors weren’t so fearful this year.\nAfter the S&P 500 recorded its biggest monthly loss since the start of the coronavirus pandemic in September, the broad index rebounded more than 6% in October on further signs that corporate profits are growing once again following last year's recession.\n“It looks as though the market has resisted ‘Octoberphobia’ and averted the feared crashes or massacres that have given the month its bad reputation,” Jeff Hirsch, editor of the Stock Trader's Almanac, said in a note to clients.\nTo be sure, November has taken hits during bear markets, when major averages drop more than 20% from a recent peak.\nFor instance, November 2000 was the Nasdaq Composite’s second-worst month on record, with the technology-focused index plunging nearly 23%, according to the Stock Trader’s Almanac. Only October 1987 was worse, and that is when the \"Black Monday\" stock market crash occurred\nWhy investors should be optimistic\nThe U.S. economy slowed substantially from July through September following a series of obstacles, including a surge in COVID-19 cases, supply chain bottlenecks, rising consumer prices and the fading effects of federal stimulus measures.\nBut with COVID-19 cases now falling and vaccinations rising, most economists are branding the weak showing a soft patch in a still-robust recovery from the pandemic-induced recession, with a healthy rebound projected in the final months of the year.\nThere are signs that there could be more gains to come on Wall Street in the final months of the year on strong seasonality trends, better-than-expected corporate earnings and falling COVID-19 cases. Market breadth has also improved, meaning that more stocks are participating in the rally, a sign of a healthy and strong market.\nJobless claims have also fallen steadily in recent weeks, with continuing claims sliding below 2.5 million recently for the first time since the coronavirus pandemic began.\nAfter suffering its first 5% pullback of 2021 in early October, the S&P 500 has come roaring back and closed at a record high on October 21. The S&P 500 Index has gained more than 20% so far this year, making more than 50 record highs along the way.\nThat could be a positive sign for investors in the coming months. The past seven times the S&P 500 had risen 15% for the year heading into the fourth quarter, that final quarter ended up higher each time, rising 5.8%, data from LPL Financial showed.\n“We firmly believe that new highs are something to be embraced, not feared, and history shows that new highs tend to come in bunches—something that has certainly been true so far this year,” according to Detrick.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699595170,"gmtCreate":1639833160564,"gmtModify":1639833202776,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699595170","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=zh_CN&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-18 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608729915,"gmtCreate":1638792989069,"gmtModify":1638792989433,"author":{"id":"3586729579943152","authorId":"3586729579943152","name":"KLF","avatar":"https://static.tigerbbs.com/2fae2086471df858a825be369f606ecc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586729579943152","authorIdStr":"3586729579943152"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608729915","repostId":"1191592715","repostType":4,"repost":{"id":"1191592715","kind":"news","pubTimestamp":1638792050,"share":"https://www.laohu8.com/m/news/1191592715?lang=zh_CN&edition=full","pubTime":"2021-12-06 20:00","market":"us","language":"en","title":"Apple Stock: Slowing iPhone Demand Or Strong Quarter Ahead?<blockquote>苹果股票：iPhone需求放缓还是未来季度强劲？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191592715","media":"TheStreet","summary":"Following evidence that Apple would have a strong holiday quarter of sales, Apple stock dipped on re","content":"<p>Following evidence that Apple would have a strong holiday quarter of sales, Apple stock dipped on reports of slowing demand for the iPhone. Here is how investors should approach this conundrum.</p><p><blockquote>有证据表明苹果假日季度销售将强劲，苹果股价因iPhone需求放缓的报道而下跌。以下是投资者应该如何解决这个难题。</blockquote></p><p> Apple stock&nbsp;investors have been scratching their heads. After shares&nbsp;endured the recent volatility in the stock market&nbsp;with flying colors, AAPL dipped on a day when the S&amp;P 500 climbed strongly. The culprit: a Bloomberg&nbsp;report&nbsp;suggesting that iPhone demand could slow down through the rest of the holiday season.</p><p><blockquote>苹果股票投资者一直在挠头。在经历了近期股市的波动后，苹果公司在标普500强劲攀升的一天下跌。罪魁祸首：彭博的一份报告表明，iPhone的需求可能会在假期的剩余时间里放缓。</blockquote></p><p> Afterall, will Apple’s 2021 shopping season be strong,as many analysts have suggested recently? Or will the supply chain crisis cause the iPhone segment to hiccup? And what should investors do about it?</p><p><blockquote>毕竟，苹果2021年的购物季会像许多分析师最近暗示的那样强劲吗？还是供应链危机会导致iPhone细分市场打嗝？投资者应该对此做些什么？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7ed8a6ea4a33d29dfca51bc0ce06a85b\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple's new iPhone 13 model.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：苹果新款iPhone 13机型。</span></p></blockquote></p><p> <b>iPhone 13: conflicting information</b></p><p><blockquote><b>iPhone 13：相互矛盾的信息</b></blockquote></p><p> According to Bloomberg, Apple has&nbsp;communicated&nbsp;to its parts suppliers that demand for the iPhone 13 is expected to cool off. The device’s production target has allegedly been cut by around 10% from an initial goal of 90 million, and even this reduced figure may now be at risk.</p><p><blockquote>据彭博社报道，苹果已经与其零部件供应商沟通，预计iPhone 13的需求将降温。据称，该设备的生产目标已从最初的9000万个目标削减了约10%，甚至这一减少的数字现在也可能面临风险。</blockquote></p><p> The problem is the supply chain crisis that has increased lead times on the smartphone, causing more impatient consumers to postpone or even give up on their purchases for the holiday season. This is in line with Bernstein analyst Toni Sacconaghi’s observations that wait times for the iPhone 13 have indeed come down, but the higher-end models may still not be delivered for another few weeks.</p><p><blockquote>问题在于供应链危机增加了智能手机的交货时间，导致更多不耐烦的消费者推迟甚至放弃假期购物。这与Bernstein分析师Toni Sacconaghi的观察一致，即iPhone 13的等待时间确实有所下降，但更高端的机型可能仍要再过几周才能交付。</blockquote></p><p> The above is at odds with what other Wall Street analysts have been reporting lately. As recently as December 1, Wedbush’s Dan Ives upped his price target on Apple stock to a Street-high $200 per share,claiming&nbsp;the following:</p><p><blockquote>上述情况与其他华尔街分析师最近的报道不一致。就在12月1日，Wedbush的Dan Ives将苹果股票的目标价上调至每股200美元的华尔街高点，并声称：</blockquote></p><p>   “Our iPhone 13 checks continue to be much stronger than expected with our belief that Apple is now on pace to sell north of 40 million iPhones during the holiday season.”  He elaborated further during a December 2&nbsp;interview&nbsp;with CNBC. Dan Ives says that production cycles can ebb and flow, and that the reported slowdown in demand could be relative to Apple’s alleged decision to order up to 10 million more units going into the season — maybe an early strategy to anticipate the production and logistic challenges.</p><p><blockquote>“我们的iPhone 13检查继续远强于预期，我们相信苹果目前有望在假期期间售出超过4000万部iPhone。”他在12月2日接受CNBC采访时进一步阐述了这一点。Dan Ives表示，生产周期可能会潮起潮落，据报道的需求放缓可能与苹果据称决定在本季再订购多达1000万辆有关——这可能是预测生产和物流挑战的早期策略。</blockquote></p><p> <b>What should AAPL investors do?</b></p><p><blockquote><b>AAPL投资者应该做什么？</b></blockquote></p><p> Demand for the iPhone in the shopping season has now become a he said, she said story. Professional research teams tasked with projecting quarter-to-quarter sales may want to get to the bottom of this issue. But I believe long-term investors should shift the focus of the attention.</p><p><blockquote>购物季对iPhone的需求现在已经成为一个他说，她说的故事。负责预测季度销售额的专业研究团队可能希望弄清这个问题的真相。但我认为长期投资者应该转移注意力。</blockquote></p><p> The question of whether to own Apple stock over the long run, in my view, transcends the debate of how many iPhones Apple may sell in the next few weeks. Other factors like long-term growth driven by services and new technologies (think mixed reality and electric vehicles) along with stock valuations matter most, in my opinion.</p><p><blockquote>在我看来，是否长期持有苹果股票的问题超越了未来几周苹果可能销售多少部iPhone的争论。在我看来，其他因素，如服务和新技术（想想混合现实和电动汽车）推动的长期增长以及股票估值最重要。</blockquote></p><p> I maintain my convictions that AAPL deserves to be a top holding in most equity portfolios. That said,I have warned readers&nbsp;about the possibility of the stock underperforming the S&amp;P 500 in the immediate future, following the vicious late November rally.</p><p><blockquote>我仍然坚信AAPL值得成为大多数股票投资组合中的顶级持股。也就是说，我已经警告读者，继11月底的恶性反弹之后，该股在不久的将来的表现可能会逊于标普500。</blockquote></p><p> Therefore, I would hold on to Apple, but only add to the position if shares shed some of their recently accumulated gains over the broad market index.</p><p><blockquote>因此，我会持有苹果，但只有在股价相对于大盘指数放弃近期积累的部分涨幅时，我才会增持头寸。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: Slowing iPhone Demand Or Strong Quarter Ahead?<blockquote>苹果股票：iPhone需求放缓还是未来季度强劲？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: Slowing iPhone Demand Or Strong Quarter Ahead?<blockquote>苹果股票：iPhone需求放缓还是未来季度强劲？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-06 20:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Following evidence that Apple would have a strong holiday quarter of sales, Apple stock dipped on reports of slowing demand for the iPhone. Here is how investors should approach this conundrum.</p><p><blockquote>有证据表明苹果假日季度销售将强劲，苹果股价因iPhone需求放缓的报道而下跌。以下是投资者应该如何解决这个难题。</blockquote></p><p> Apple stock&nbsp;investors have been scratching their heads. After shares&nbsp;endured the recent volatility in the stock market&nbsp;with flying colors, AAPL dipped on a day when the S&amp;P 500 climbed strongly. The culprit: a Bloomberg&nbsp;report&nbsp;suggesting that iPhone demand could slow down through the rest of the holiday season.</p><p><blockquote>苹果股票投资者一直在挠头。在经历了近期股市的波动后，苹果公司在标普500强劲攀升的一天下跌。罪魁祸首：彭博的一份报告表明，iPhone的需求可能会在假期的剩余时间里放缓。</blockquote></p><p> Afterall, will Apple’s 2021 shopping season be strong,as many analysts have suggested recently? Or will the supply chain crisis cause the iPhone segment to hiccup? And what should investors do about it?</p><p><blockquote>毕竟，苹果2021年的购物季会像许多分析师最近暗示的那样强劲吗？还是供应链危机会导致iPhone细分市场打嗝？投资者应该对此做些什么？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7ed8a6ea4a33d29dfca51bc0ce06a85b\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple's new iPhone 13 model.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：苹果新款iPhone 13机型。</span></p></blockquote></p><p> <b>iPhone 13: conflicting information</b></p><p><blockquote><b>iPhone 13：相互矛盾的信息</b></blockquote></p><p> According to Bloomberg, Apple has&nbsp;communicated&nbsp;to its parts suppliers that demand for the iPhone 13 is expected to cool off. The device’s production target has allegedly been cut by around 10% from an initial goal of 90 million, and even this reduced figure may now be at risk.</p><p><blockquote>据彭博社报道，苹果已经与其零部件供应商沟通，预计iPhone 13的需求将降温。据称，该设备的生产目标已从最初的9000万个目标削减了约10%，甚至这一减少的数字现在也可能面临风险。</blockquote></p><p> The problem is the supply chain crisis that has increased lead times on the smartphone, causing more impatient consumers to postpone or even give up on their purchases for the holiday season. This is in line with Bernstein analyst Toni Sacconaghi’s observations that wait times for the iPhone 13 have indeed come down, but the higher-end models may still not be delivered for another few weeks.</p><p><blockquote>问题在于供应链危机增加了智能手机的交货时间，导致更多不耐烦的消费者推迟甚至放弃假期购物。这与Bernstein分析师Toni Sacconaghi的观察一致，即iPhone 13的等待时间确实有所下降，但更高端的机型可能仍要再过几周才能交付。</blockquote></p><p> The above is at odds with what other Wall Street analysts have been reporting lately. As recently as December 1, Wedbush’s Dan Ives upped his price target on Apple stock to a Street-high $200 per share,claiming&nbsp;the following:</p><p><blockquote>上述情况与其他华尔街分析师最近的报道不一致。就在12月1日，Wedbush的Dan Ives将苹果股票的目标价上调至每股200美元的华尔街高点，并声称：</blockquote></p><p>   “Our iPhone 13 checks continue to be much stronger than expected with our belief that Apple is now on pace to sell north of 40 million iPhones during the holiday season.”  He elaborated further during a December 2&nbsp;interview&nbsp;with CNBC. Dan Ives says that production cycles can ebb and flow, and that the reported slowdown in demand could be relative to Apple’s alleged decision to order up to 10 million more units going into the season — maybe an early strategy to anticipate the production and logistic challenges.</p><p><blockquote>“我们的iPhone 13检查继续远强于预期，我们相信苹果目前有望在假期期间售出超过4000万部iPhone。”他在12月2日接受CNBC采访时进一步阐述了这一点。Dan Ives表示，生产周期可能会潮起潮落，据报道的需求放缓可能与苹果据称决定在本季再订购多达1000万辆有关——这可能是预测生产和物流挑战的早期策略。</blockquote></p><p> <b>What should AAPL investors do?</b></p><p><blockquote><b>AAPL投资者应该做什么？</b></blockquote></p><p> Demand for the iPhone in the shopping season has now become a he said, she said story. Professional research teams tasked with projecting quarter-to-quarter sales may want to get to the bottom of this issue. But I believe long-term investors should shift the focus of the attention.</p><p><blockquote>购物季对iPhone的需求现在已经成为一个他说，她说的故事。负责预测季度销售额的专业研究团队可能希望弄清这个问题的真相。但我认为长期投资者应该转移注意力。</blockquote></p><p> The question of whether to own Apple stock over the long run, in my view, transcends the debate of how many iPhones Apple may sell in the next few weeks. Other factors like long-term growth driven by services and new technologies (think mixed reality and electric vehicles) along with stock valuations matter most, in my opinion.</p><p><blockquote>在我看来，是否长期持有苹果股票的问题超越了未来几周苹果可能销售多少部iPhone的争论。在我看来，其他因素，如服务和新技术（想想混合现实和电动汽车）推动的长期增长以及股票估值最重要。</blockquote></p><p> I maintain my convictions that AAPL deserves to be a top holding in most equity portfolios. That said,I have warned readers&nbsp;about the possibility of the stock underperforming the S&amp;P 500 in the immediate future, following the vicious late November rally.</p><p><blockquote>我仍然坚信AAPL值得成为大多数股票投资组合中的顶级持股。也就是说，我已经警告读者，继11月底的恶性反弹之后，该股在不久的将来的表现可能会逊于标普500。</blockquote></p><p> Therefore, I would hold on to Apple, but only add to the position if shares shed some of their recently accumulated gains over the broad market index.</p><p><blockquote>因此，我会持有苹果，但只有在股价相对于大盘指数放弃近期积累的部分涨幅时，我才会增持头寸。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/apple/iphone/apple-stock-slowing-iphone-demand-or-strong-quarter-ahead\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/apple-stock-slowing-iphone-demand-or-strong-quarter-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191592715","content_text":"Following evidence that Apple would have a strong holiday quarter of sales, Apple stock dipped on reports of slowing demand for the iPhone. Here is how investors should approach this conundrum.\nApple stock investors have been scratching their heads. After shares endured the recent volatility in the stock market with flying colors, AAPL dipped on a day when the S&P 500 climbed strongly. The culprit: a Bloomberg report suggesting that iPhone demand could slow down through the rest of the holiday season.\nAfterall, will Apple’s 2021 shopping season be strong,as many analysts have suggested recently? Or will the supply chain crisis cause the iPhone segment to hiccup? And what should investors do about it?\nFigure 1: Apple's new iPhone 13 model.\niPhone 13: conflicting information\nAccording to Bloomberg, Apple has communicated to its parts suppliers that demand for the iPhone 13 is expected to cool off. The device’s production target has allegedly been cut by around 10% from an initial goal of 90 million, and even this reduced figure may now be at risk.\nThe problem is the supply chain crisis that has increased lead times on the smartphone, causing more impatient consumers to postpone or even give up on their purchases for the holiday season. This is in line with Bernstein analyst Toni Sacconaghi’s observations that wait times for the iPhone 13 have indeed come down, but the higher-end models may still not be delivered for another few weeks.\nThe above is at odds with what other Wall Street analysts have been reporting lately. As recently as December 1, Wedbush’s Dan Ives upped his price target on Apple stock to a Street-high $200 per share,claiming the following:\n\n “Our iPhone 13 checks continue to be much stronger than expected with our belief that Apple is now on pace to sell north of 40 million iPhones during the holiday season.”\n\nHe elaborated further during a December 2 interview with CNBC. Dan Ives says that production cycles can ebb and flow, and that the reported slowdown in demand could be relative to Apple’s alleged decision to order up to 10 million more units going into the season — maybe an early strategy to anticipate the production and logistic challenges.\nWhat should AAPL investors do?\nDemand for the iPhone in the shopping season has now become a he said, she said story. Professional research teams tasked with projecting quarter-to-quarter sales may want to get to the bottom of this issue. But I believe long-term investors should shift the focus of the attention.\nThe question of whether to own Apple stock over the long run, in my view, transcends the debate of how many iPhones Apple may sell in the next few weeks. Other factors like long-term growth driven by services and new technologies (think mixed reality and electric vehicles) along with stock valuations matter most, in my opinion.\nI maintain my convictions that AAPL deserves to be a top holding in most equity portfolios. That said,I have warned readers about the possibility of the stock underperforming the S&P 500 in the immediate future, following the vicious late November rally.\nTherefore, I would hold on to Apple, but only add to the position if shares shed some of their recently accumulated gains over the broad market index.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}